| 13827687 | CV578635 | single nucleotide variant | NM_006567.5(FARS2):c.*4C>T | Combined oxidative phosphorylation defect type 14 [RCV000714911] | uncertain significance | 6 | 5771433 | 5771433 | Human | 1 | name |
| 150458384 | CV1278761 | single nucleotide variant | NM_006567.5(FARS2):c.-70A>G | not provided [RCV001709378] | benign | 6 | 5261612 | 5261612 | Human | | name |
| 150335900 | CV1171602 | single nucleotide variant | NM_006567.4(FARS2):c.-307T>C | not provided [RCV001540754] | benign | 6 | 5261375 | 5261375 | Human | | name |
| 150419968 | CV1180207 | single nucleotide variant | NM_006567.4(FARS2):c.-262G>C | not provided [RCV001551317] | likely benign | 6 | 5261420 | 5261420 | Human | | name |
| 150435696 | CV1233933 | single nucleotide variant | NM_006567.4(FARS2):c.-312T>C | not provided [RCV001644060] | benign | 6 | 5261370 | 5261370 | Human | | name |
| 150492542 | CV1238498 | single nucleotide variant | NM_006567.4(FARS2):c.-314T>C | not provided [RCV001655042] | benign | 6 | 5261368 | 5261368 | Human | | name |
| 150436415 | CV1249692 | single nucleotide variant | NM_006567.4(FARS2):c.-340T>C | not provided [RCV001665606] | benign | 6 | 5261342 | 5261342 | Human | | name |
| 150472140 | CV1281148 | single nucleotide variant | NM_006567.4(FARS2):c.-234A>G | not provided [RCV001713319] | benign | 6 | 5261448 | 5261448 | Human | | name |
| 126920838 | CV1044195 | single nucleotide variant | NM_006567.5(FARS2):c.904+3A>G | Combined oxidative phosphorylation defect type 14 [RCV001363111] | uncertain significance | 6 | 5431175 | 5431175 | Human | 1 | name |
| 127319358 | CV1137780 | single nucleotide variant | NM_006567.5(FARS2):c.904+9G>T | Combined oxidative phosphorylation defect type 14 [RCV001503996] | likely benign | 6 | 5431181 | 5431181 | Human | 1 | name |
| 156413171 | CV1887717 | single nucleotide variant | NM_006567.5(FARS2):c.773-7T>C | Combined oxidative phosphorylation defect type 14 [RCV003073186] | likely benign | 6 | 5431034 | 5431034 | Human | 1 | name |
| 156315282 | CV1901176 | single nucleotide variant | NM_006567.5(FARS2):c.772+4A>G | Combined oxidative phosphorylation defect type 14 [RCV002578918] | uncertain significance | 6 | 5404705 | 5404705 | Human | 1 | name |
| 155910788 | CV2084679 | single nucleotide variant | NM_006567.5(FARS2):c.773-9A>C | Combined oxidative phosphorylation defect type 14 [RCV002858471] | likely benign | 6 | 5431032 | 5431032 | Human | 1 | name |
| 156156690 | CV2142484 | single nucleotide variant | NM_006567.5(FARS2):c.613-2A>G | Combined oxidative phosphorylation defect type 14 [RCV002982845] | likely pathogenic | 6 | 5404540 | 5404540 | Human | 1 | name |
| 156258342 | CV2219973 | single nucleotide variant | NM_006567.5(FARS2):c.773-6T>A | Inborn genetic diseases [RCV002702868] | uncertain significance | 6 | 5431035 | 5431035 | Human | 1 | name |
| 405013793 | CV2954772 | single nucleotide variant | NM_006567.5(FARS2):c.613-9G>C | Combined oxidative phosphorylation defect type 14 [RCV003649596] | likely benign | 6 | 5404533 | 5404533 | Human | 1 | name |
| 405016422 | CV3046263 | single nucleotide variant | NM_006567.5(FARS2):c.772+7G>A | Combined oxidative phosphorylation defect type 14 [RCV003649919] | likely benign | 6 | 5404708 | 5404708 | Human | 1 | name |
| 597902437 | CV3851445 | single nucleotide variant | NM_006567.5(FARS2):c.772+2T>A | Combined oxidative phosphorylation defect type 14 [RCV005202222] | likely pathogenic | 6 | 5404703 | 5404703 | Human | 1 | name |
| 13491622 | CV455657 | single nucleotide variant | NM_006567.5(FARS2):c.613-4A>G | Combined oxidative phosphorylation defect type 14 [RCV000534362] | likely benign | 6 | 5404538 | 5404538 | Human | 1 | name |
| 13827717 | CV578623 | single nucleotide variant | NM_006567.5(FARS2):c.905-1G>A | Combined oxidative phosphorylation defect type 14 [RCV000714949] | likely pathogenic | 6 | 5545179 | 5545179 | Human | 1 | name |
| 15120096 | CV775238 | single nucleotide variant | NM_006567.5(FARS2):c.905-5C>T | Combined oxidative phosphorylation defect type 14 [RCV001466751] | likely benign | 6 | 5545175 | 5545175 | Human | 1 | name |
| 15133464 | CV787413 | single nucleotide variant | NM_006567.5(FARS2):c.904+9G>C | Combined oxidative phosphorylation defect type 14 [RCV000981556] | likely benign | 6 | 5431181 | 5431181 | Human | 1 | name |
| 38484821 | CV959808 | single nucleotide variant | NM_006567.5(FARS2):c.772+4A>C | Combined oxidative phosphorylation defect type 14 [RCV001236527] | uncertain significance | 6 | 5404705 | 5404705 | Human | 1 | name |
| 127240170 | CV1095305 | deletion | NM_006567.5(FARS2):c.904+16del | Combined oxidative phosphorylation defect type 14 [RCV001423252] | likely benign | 6 | 5431188 | 5431188 | Human | 1 | name |
| 127266279 | CV1095390 | single nucleotide variant | NM_006567.5(FARS2):c.1218-5T>C | Combined oxidative phosphorylation defect type 14 [RCV001440203] | likely benign | 6 | 5771286 | 5771286 | Human | 1 | name |
| 150406045 | CV1193812 | single nucleotide variant | NM_006567.5(FARS2):c.772+25G>A | not provided [RCV001571902] | likely benign | 6 | 5404726 | 5404726 | Human | | name |
| 150405918 | CV1193813 | single nucleotide variant | NM_006567.5(FARS2):c.905-45A>G | not provided [RCV001571847] | likely benign | 6 | 5545135 | 5545135 | Human | | name |
| 150433222 | CV1203604 | single nucleotide variant | NM_006567.5(FARS2):c.612+48T>G | not provided [RCV001581760] | likely benign | 6 | 5369230 | 5369230 | Human | | name |
| 150433253 | CV1203614 | single nucleotide variant | NM_006567.5(FARS2):c.905-40G>A | not provided [RCV001581770] | likely benign | 6 | 5545140 | 5545140 | Human | | name |
| 150495646 | CV1225127 | single nucleotide variant | NM_006567.5(FARS2):c.772+24C>T | not provided [RCV001619605]|not specified [RCV004598057] | benign | 6 | 5404725 | 5404725 | Human | | name |
| 150459926 | CV1231254 | deletion | NM_006567.5(FARS2):c.772+86del | not provided [RCV001640818] | benign | 6 | 5404772 | 5404772 | Human | | name |
| 150490482 | CV1239125 | single nucleotide variant | NM_006567.5(FARS2):c.-22+94A>T | not provided [RCV001654693] | benign | 6 | 5261754 | 5261754 | Human | | name |
| 150443519 | CV1277870 | duplication | NM_006567.5(FARS2):c.772+86dup | not provided [RCV001707013] | benign | 6 | 5404771 | 5404772 | Human | | name |
| 151233354 | CV1320325 | single nucleotide variant | NM_001318872.2(FARS2):c.-73C>T | not provided [RCV001799949] | benign | 6 | 5261307 | 5261307 | Human | | name |
| 151726210 | CV1415926 | single nucleotide variant | NM_006567.5(FARS2):c.1066-9T>G | Combined oxidative phosphorylation defect type 14 [RCV001945554] | likely benign|uncertain significance | 6 | 5613160 | 5613160 | Human | 1 | name |
| 151774498 | CV1440081 | single nucleotide variant | NM_006567.5(FARS2):c.1217+4A>G | Combined oxidative phosphorylation defect type 14 [RCV001874766] | uncertain significance | 6 | 5613324 | 5613324 | Human | 1 | name |
| 152058082 | CV1523290 | single nucleotide variant | NM_006567.5(FARS2):c.612+19C>A | Combined oxidative phosphorylation defect type 14 [RCV002167687] | likely benign | 6 | 5369201 | 5369201 | Human | 1 | name |
| 152120051 | CV1547199 | single nucleotide variant | NM_006567.5(FARS2):c.1218-7T>C | Combined oxidative phosphorylation defect type 14 [RCV002154138] | likely benign | 6 | 5771284 | 5771284 | Human | 1 | name |
| 152087126 | CV1601138 | single nucleotide variant | NM_006567.5(FARS2):c.612+12G>A | Combined oxidative phosphorylation defect type 14 [RCV002093637] | likely benign | 6 | 5369194 | 5369194 | Human | 1 | name |
| 156161508 | CV1872355 | single nucleotide variant | NM_006567.5(FARS2):c.772+20T>C | Combined oxidative phosphorylation defect type 14 [RCV003056922] | likely benign | 6 | 5404721 | 5404721 | Human | 1 | name |
| 156353578 | CV1974844 | single nucleotide variant | NM_006567.5(FARS2):c.905-20A>C | Combined oxidative phosphorylation defect type 14 [RCV002602002] | likely benign | 6 | 5545160 | 5545160 | Human | 1 | name |
| 156399463 | CV2013185 | single nucleotide variant | NM_006567.5(FARS2):c.773-17C>T | Combined oxidative phosphorylation defect type 14 [RCV002725873] | likely benign | 6 | 5431024 | 5431024 | Human | 1 | name |
| 156016543 | CV2177533 | single nucleotide variant | NM_006567.5(FARS2):c.904+16A>G | Combined oxidative phosphorylation defect type 14 [RCV003035514] | likely benign | 6 | 5431188 | 5431188 | Human | 1 | name |
| 405083759 | CV2899952 | single nucleotide variant | NM_006567.5(FARS2):c.772+11A>T | Combined oxidative phosphorylation defect type 14 [RCV003535401] | likely benign | 6 | 5404712 | 5404712 | Human | 1 | name |
| 405092535 | CV2907705 | single nucleotide variant | NM_006567.5(FARS2):c.613-10T>G | Combined oxidative phosphorylation defect type 14 [RCV003536590] | likely benign | 6 | 5404532 | 5404532 | Human | 1 | name |
| 405013239 | CV2953424 | single nucleotide variant | NM_006567.5(FARS2):c.613-13T>C | Combined oxidative phosphorylation defect type 14 [RCV003649558] | likely benign | 6 | 5404529 | 5404529 | Human | 1 | name |
| 405024373 | CV2991185 | single nucleotide variant | NM_006567.5(FARS2):c.613-15C>A | Combined oxidative phosphorylation defect type 14 [RCV003651219] | likely benign | 6 | 5404527 | 5404527 | Human | 1 | name |
| 405032931 | CV2997114 | single nucleotide variant | NM_006567.5(FARS2):c.904+11A>T | Combined oxidative phosphorylation defect type 14 [RCV003652387] | likely benign | 6 | 5431183 | 5431183 | Human | 1 | name |
| 405044780 | CV3034483 | single nucleotide variant | NM_006567.5(FARS2):c.1066-5G>T | Combined oxidative phosphorylation defect type 14 [RCV003654017] | likely benign | 6 | 5613164 | 5613164 | Human | 1 | name |
| 405006719 | CV3117541 | single nucleotide variant | NM_006567.5(FARS2):c.613-18T>C | Combined oxidative phosphorylation defect type 14 [RCV003828596] | likely benign | 6 | 5404524 | 5404524 | Human | 1 | name |
| 597953577 | CV3776448 | single nucleotide variant | NM_006567.5(FARS2):c.612+14T>A | Combined oxidative phosphorylation defect type 14 [RCV005121576] | likely benign | 6 | 5369196 | 5369196 | Human | 1 | name |
| 597932028 | CV3786114 | single nucleotide variant | NM_006567.5(FARS2):c.613-11T>A | Combined oxidative phosphorylation defect type 14 [RCV005131822] | likely benign | 6 | 5404531 | 5404531 | Human | 1 | name |
| 597940556 | CV3836584 | single nucleotide variant | NM_006567.5(FARS2):c.904+18A>G | Combined oxidative phosphorylation defect type 14 [RCV005187605] | likely benign | 6 | 5431190 | 5431190 | Human | 1 | name |
| 597916060 | CV3845719 | single nucleotide variant | NM_006567.5(FARS2):c.772+17A>C | Combined oxidative phosphorylation defect type 14 [RCV005183514] | likely benign | 6 | 5404718 | 5404718 | Human | 1 | name |
| 13827695 | CV578617 | single nucleotide variant | NM_006567.5(FARS2):c.613-11T>C | Combined oxidative phosphorylation defect type 14 [RCV000714921] | likely benign | 6 | 5404531 | 5404531 | Human | 1 | name |
| 15108940 | CV787546 | single nucleotide variant | NM_006567.5(FARS2):c.905-10C>T | not provided [RCV000977133] | likely benign | 6 | 5545170 | 5545170 | Human | | name |
| 126758466 | CV991635 | single nucleotide variant | NM_006567.5(FARS2):c.1218-9T>A | Combined oxidative phosphorylation defect type 14 [RCV001299194] | likely benign|uncertain significance | 6 | 5771282 | 5771282 | Human | 1 | name |
| 127320856 | CV1137782 | single nucleotide variant | NM_006567.5(FARS2):c.1066-10G>A | Combined oxidative phosphorylation defect type 14 [RCV001484367] | likely benign | 6 | 5613159 | 5613159 | Human | 1 | name |
| 150424297 | CV1183859 | single nucleotide variant | NM_006567.5(FARS2):c.-21-272C>T | not provided [RCV001556476] | likely benign | 6 | 5368278 | 5368278 | Human | | name |
| 150459187 | CV1202890 | single nucleotide variant | NM_006567.5(FARS2):c.1218-67C>A | not provided [RCV001586543] | likely benign | 6 | 5771224 | 5771224 | Human | | name |
| 150479033 | CV1207769 | single nucleotide variant | NM_006567.5(FARS2):c.904+142G>A | not provided [RCV001590045] | likely benign | 6 | 5431314 | 5431314 | Human | | name |
| 150460985 | CV1231419 | single nucleotide variant | NM_006567.5(FARS2):c.1065+81C>T | not provided [RCV001640984]|not specified [RCV004598063] | benign | 6 | 5545421 | 5545421 | Human | | name |
| 150450641 | CV1232703 | single nucleotide variant | NM_006567.5(FARS2):c.612+245C>T | not provided [RCV001647778] | benign | 6 | 5369427 | 5369427 | Human | | name |
| 152131746 | CV1521766 | single nucleotide variant | NM_006567.5(FARS2):c.1066-19T>C | Combined oxidative phosphorylation defect type 14 [RCV002199419] | likely benign | 6 | 5613150 | 5613150 | Human | 1 | name |
| 152133547 | CV1545018 | single nucleotide variant | NM_006567.5(FARS2):c.1066-12T>A | Combined oxidative phosphorylation defect type 14 [RCV002177123] | likely benign | 6 | 5613157 | 5613157 | Human | 1 | name |
| 152148477 | CV1569025 | single nucleotide variant | NM_006567.5(FARS2):c.1065+14C>G | Combined oxidative phosphorylation defect type 14 [RCV002220420] | likely benign | 6 | 5545354 | 5545354 | Human | 1 | name |
| 152058412 | CV1652010 | single nucleotide variant | NM_006567.5(FARS2):c.1066-13C>T | Combined oxidative phosphorylation defect type 14 [RCV002190239] | likely benign | 6 | 5613156 | 5613156 | Human | 1 | name |
| 156391839 | CV1995794 | single nucleotide variant | NM_006567.5(FARS2):c.1066-12T>C | Combined oxidative phosphorylation defect type 14 [RCV002680842] | likely benign | 6 | 5613157 | 5613157 | Human | 1 | name |
| 156014863 | CV2061549 | single nucleotide variant | NM_006567.5(FARS2):c.1066-15C>T | Combined oxidative phosphorylation defect type 14 [RCV002820321] | likely benign | 6 | 5613154 | 5613154 | Human | 1 | name |
| 156360445 | CV2184142 | single nucleotide variant | NM_006567.5(FARS2):c.1066-17T>C | Combined oxidative phosphorylation defect type 14 [RCV003048987] | likely benign | 6 | 5613152 | 5613152 | Human | 1 | name |
| 407455615 | CV3415613 | single nucleotide variant | NM_006567.5(FARS2):c.904+555A>G | not specified [RCV004598496] | benign | 6 | 5431727 | 5431727 | Human | | name |
| 13535429 | CV502020 | deletion | NM_006567.5(FARS2):c.1217+11del | not specified [RCV000602336] | likely benign | 6 | 5613328 | 5613328 | Human | | name |
| 13827704 | CV578629 | single nucleotide variant | NM_006567.5(FARS2):c.1066-15C>G | Combined oxidative phosphorylation defect type 14 [RCV000714932] | likely benign | 6 | 5613154 | 5613154 | Human | 1 | name |
| 14741482 | CV661810 | single nucleotide variant | NM_006567.5(FARS2):c.612+261G>A | not provided [RCV000840803] | likely benign | 6 | 5369443 | 5369443 | Human | | name |
| 14740480 | CV661812 | single nucleotide variant | NM_006567.5(FARS2):c.904+166G>A | not provided [RCV000840365] | benign | 6 | 5431338 | 5431338 | Human | | name |
| 14740497 | CV662178 | single nucleotide variant | NM_006567.5(FARS2):c.612+323C>T | not provided [RCV000840372] | benign | 6 | 5369505 | 5369505 | Human | | name |
| 14724268 | CV662183 | single nucleotide variant | NM_006567.5(FARS2):c.772+133C>T | not provided [RCV000832906] | benign | 6 | 5404834 | 5404834 | Human | | name |
| 14741407 | CV662263 | single nucleotide variant | NM_006567.5(FARS2):c.613-315T>A | not provided [RCV000840772] | benign | 6 | 5404227 | 5404227 | Human | | name |
| 14740647 | CV662266 | single nucleotide variant | NM_006567.5(FARS2):c.613-188C>T | not provided [RCV000840434] | benign | 6 | 5404354 | 5404354 | Human | | name |
| 150425505 | CV1183860 | single nucleotide variant | NM_006567.5(FARS2):c.1066-225T>C | not provided [RCV001558079] | likely benign | 6 | 5612944 | 5612944 | Human | | name |
| 150511829 | CV1242812 | single nucleotide variant | NM_006567.5(FARS2):c.1066-295A>T | not provided [RCV001661165] | benign | 6 | 5612874 | 5612874 | Human | | name |
| 150445451 | CV1278154 | single nucleotide variant | NM_006567.5(FARS2):c.1065+282G>A | not provided [RCV001707297] | benign | 6 | 5545622 | 5545622 | Human | | name |
| 14740763 | CV661830 | single nucleotide variant | NM_006567.5(FARS2):c.1066-247G>A | not provided [RCV000840481] | benign | 6 | 5612922 | 5612922 | Human | | name |
| 14740499 | CV662256 | single nucleotide variant | NM_006567.5(FARS2):c.1065+243A>G | not provided [RCV000840373] | benign | 6 | 5545583 | 5545583 | Human | | name |
| 8581981 | CV116433 | single nucleotide variant | NM_006567.3(FARS2):c.-21-30418A>G | Lung cancer [RCV000096956] | uncertain significance | 6 | 5338132 | 5338132 | Human | | name |
| 401797324 | CV2740931 | single nucleotide variant | NM_006567.5(FARS2):c.1065+9040A>G | not provided [RCV003322095] | uncertain significance | 6 | 5554380 | 5554380 | Human | | name |
| 407455446 | CV3415573 | single nucleotide variant | NM_006567.5(FARS2):c.1217+6135A>G | not specified [RCV004598456] | benign | 6 | 5619455 | 5619455 | Human | | name |
| 407455569 | CV3415601 | single nucleotide variant | NM_006567.5(FARS2):c.904+14334C>T | not specified [RCV004598484] | benign | 6 | 5445506 | 5445506 | Human | | name |
| 127318946 | CV1155443 | single nucleotide variant | NM_006567.5(FARS2):c.1217+40158C>T | Combined oxidative phosphorylation defect type 14 [RCV001521885] | benign | 6 | 5653478 | 5653478 | Human | 1 | name |
| 8582007 | CV116459 | single nucleotide variant | NM_006567.3(FARS2):c.1066-21092C>A | Lung cancer [RCV000096982] | uncertain significance | 6 | 5592077 | 5592077 | Human | | name |
| 8582017 | CV116469 | single nucleotide variant | NM_006567.3(FARS2):c.1217+59797G>A | Lung cancer [RCV000096992] | uncertain significance | 6 | 5673117 | 5673117 | Human | | name |
| 401797319 | CV2740930 | single nucleotide variant | NM_006567.5(FARS2):c.1217+75319G>C | not provided [RCV003322094] | uncertain significance | 6 | 5688639 | 5688639 | Human | | name |
| 401797329 | CV2740932 | single nucleotide variant | NM_006567.5(FARS2):c.1218-33495A>G | not provided [RCV003322096] | uncertain significance | 6 | 5737796 | 5737796 | Human | | name |
| 407455373 | CV3415558 | single nucleotide variant | NM_006567.5(FARS2):c.1217+37690T>C | not specified [RCV004598441] | benign | 6 | 5651010 | 5651010 | Human | | name |
| 38484487 | CV945071 | single nucleotide variant | NM_006567.5(FARS2):c.6G>A (p.Val2=) | Combined oxidative phosphorylation defect type 14 [RCV001236357] | likely benign|uncertain significance | 6 | 5368576 | 5368576 | Human | 1 | name |
| 127251136 | CV1055617 | single nucleotide variant | NM_006567.5(FARS2):c.3G>T (p.Met1Ile) | Combined oxidative phosphorylation defect type 14 [RCV001378498] | pathogenic|likely pathogenic | 6 | 5368573 | 5368573 | Human | 1 | name |
| 127265919 | CV1073711 | single nucleotide variant | NM_006567.5(FARS2):c.72C>T (p.Ser24=) | Combined oxidative phosphorylation defect type 14 [RCV001403710] | likely benign | 6 | 5368642 | 5368642 | Human | 1 | name |
| 127282363 | CV1095300 | single nucleotide variant | NM_006567.5(FARS2):c.84G>A (p.Gln28=) | Combined oxidative phosphorylation defect type 14 [RCV001447764] | likely benign | 6 | 5368654 | 5368654 | Human | 1 | name |
| 127249156 | CV1095309 | microsatellite | NM_006567.5(FARS2):c.1066-7_1066-3del | Combined oxidative phosphorylation defect type 14 [RCV001436035] | likely benign | 6 | 5613157 | 5613161 | Human | | name |
| 156034092 | CV2059298 | single nucleotide variant | NM_006567.5(FARS2):c.7G>A (p.Gly3Ser) | Combined oxidative phosphorylation defect type 14 [RCV002796177] | uncertain significance | 6 | 5368577 | 5368577 | Human | 1 | name |
| 597964221 | CV3792139 | single nucleotide variant | NM_006567.5(FARS2):c.1A>G (p.Met1Val) | Combined oxidative phosphorylation defect type 14 [RCV005139696] | pathogenic | 6 | 5368571 | 5368571 | Human | 1 | name |
| 26891443 | CV832064 | single nucleotide variant | NM_006567.5(FARS2):c.4G>T (p.Val2Leu) | Combined oxidative phosphorylation defect type 14 [RCV001068257] | uncertain significance | 6 | 5368574 | 5368574 | Human | 1 | name |
| 38596840 | CV963613 | single nucleotide variant | NM_006567.5(FARS2):c.8G>T (p.Gly3Val) | Intellectual disability [RCV001252485] | likely benign | 6 | 5368578 | 5368578 | Human | 2 | name |
| 127236861 | CV1073712 | single nucleotide variant | NM_006567.5(FARS2):c.150G>A (p.Val50=) | Combined oxidative phosphorylation defect type 14 [RCV001396980] | likely benign | 6 | 5368720 | 5368720 | Human | 1 | name |
| 127263003 | CV1095301 | single nucleotide variant | NM_006567.5(FARS2):c.138T>C (p.Ala46=) | Combined oxidative phosphorylation defect type 14 [RCV001439185] | likely benign | 6 | 5368708 | 5368708 | Human | 1 | name |
| 127248936 | CV1095302 | single nucleotide variant | NM_006567.5(FARS2):c.213C>T (p.Leu71=) | Combined oxidative phosphorylation defect type 14 [RCV001435989]|FARS2-related disorder [RCV003973287] | likely benign | 6 | 5368783 | 5368783 | Human | 1 | name , trait , alternate_id |
| 127312622 | CV1137776 | single nucleotide variant | NM_006567.5(FARS2):c.264G>A (p.Leu88=) | Combined oxidative phosphorylation defect type 14 [RCV001501971] | likely benign | 6 | 5368834 | 5368834 | Human | 1 | name |
| 8691032 | CV140991 | single nucleotide variant | NM_006567.5(FARS2):c.102G>A (p.Ser34=) | Combined oxidative phosphorylation defect type 14 [RCV000551443]|not specified [RCV000124979] | benign | 6 | 5368672 | 5368672 | Human | 1 | name |
| 151887074 | CV1496053 | single nucleotide variant | NM_006567.5(FARS2):c.20G>A (p.Arg7Lys) | Combined oxidative phosphorylation defect type 14 [RCV001887691] | uncertain significance | 6 | 5368590 | 5368590 | Human | 1 | name |
| 152162035 | CV1543856 | single nucleotide variant | NM_006567.5(FARS2):c.160C>T (p.Leu54=) | Combined oxidative phosphorylation defect type 14 [RCV002159810] | likely benign | 6 | 5368730 | 5368730 | Human | 1 | name |
| 152047009 | CV1561538 | single nucleotide variant | NM_006567.5(FARS2):c.231C>T (p.Asn77=) | Combined oxidative phosphorylation defect type 14 [RCV002108459] | likely benign | 6 | 5368801 | 5368801 | Human | 1 | name |
| 152093642 | CV1570644 | single nucleotide variant | NM_006567.5(FARS2):c.201C>G (p.Thr67=) | Combined oxidative phosphorylation defect type 14 [RCV002213067] | likely benign | 6 | 5368771 | 5368771 | Human | 1 | name |
| 152167735 | CV1577526 | single nucleotide variant | NM_006567.5(FARS2):c.120G>A (p.Glu40=) | Combined oxidative phosphorylation defect type 14 [RCV002204787] | likely benign | 6 | 5368690 | 5368690 | Human | 1 | name |
| 156347435 | CV1995359 | single nucleotide variant | NM_006567.5(FARS2):c.204G>C (p.Arg68=) | Combined oxidative phosphorylation defect type 14 [RCV002650644] | likely benign | 6 | 5368774 | 5368774 | Human | 1 | name |
| 155970813 | CV2062457 | single nucleotide variant | NM_006567.5(FARS2):c.207G>A (p.Lys69=) | Combined oxidative phosphorylation defect type 14 [RCV002842068]|not provided [RCV003886586] | likely benign | 6 | 5368777 | 5368777 | Human | 1 | name |
| 156029998 | CV2105470 | single nucleotide variant | NM_006567.5(FARS2):c.126C>T (p.Ala42=) | Combined oxidative phosphorylation defect type 14 [RCV002910022] | likely benign | 6 | 5368696 | 5368696 | Human | 1 | name |
| 156099409 | CV2107167 | single nucleotide variant | NM_006567.5(FARS2):c.141A>G (p.Pro47=) | Combined oxidative phosphorylation defect type 14 [RCV002926991] | likely benign | 6 | 5368711 | 5368711 | Human | 1 | name |
| 11547208 | CV252444 | single nucleotide variant | NM_006567.5(FARS2):c.183C>T (p.Asp61=) | Combined oxidative phosphorylation defect type 14 [RCV000554418]|not provided [RCV003422171]|not specified [RCV000247463] | benign|likely benign | 6 | 5368753 | 5368753 | Human | 1 | name |
| 401918358 | CV2822668 | single nucleotide variant | NM_006567.5(FARS2):c.228G>A (p.Arg76=) | not provided [RCV003430083] | likely benign | 6 | 5368798 | 5368798 | Human | | name |
| 405087231 | CV2857690 | single nucleotide variant | NM_006567.5(FARS2):c.294C>T (p.Tyr98=) | Combined oxidative phosphorylation defect type 14 [RCV003536068] | likely benign | 6 | 5368864 | 5368864 | Human | 1 | name |
| 405013147 | CV2949534 | single nucleotide variant | NM_006567.5(FARS2):c.234G>T (p.Leu78=) | Combined oxidative phosphorylation defect type 14 [RCV003649547] | likely benign | 6 | 5368804 | 5368804 | Human | 1 | name |
| 405021510 | CV2977130 | single nucleotide variant | NM_006567.5(FARS2):c.262C>T (p.Leu88=) | Combined oxidative phosphorylation defect type 14 [RCV003650842] | likely benign | 6 | 5368832 | 5368832 | Human | 1 | name |
| 405042330 | CV3018839 | single nucleotide variant | NM_006567.5(FARS2):c.11C>G (p.Ser4Ter) | Combined oxidative phosphorylation defect type 14 [RCV003653811] | pathogenic | 6 | 5368581 | 5368581 | Human | 1 | name |
| 405214396 | CV3143123 | single nucleotide variant | NM_006567.5(FARS2):c.108T>C (p.Pro36=) | Combined oxidative phosphorylation defect type 14 [RCV003846286] | likely benign | 6 | 5368678 | 5368678 | Human | 1 | name |
| 597963864 | CV3754220 | deletion | NM_006567.5(FARS2):c.63del (p.His22fs) | Combined oxidative phosphorylation defect type 14 [RCV005082327] | pathogenic | 6 | 5368633 | 5368633 | Human | 1 | name |
| 13817647 | CV565749 | single nucleotide variant | NM_006567.5(FARS2):c.21G>T (p.Arg7Ser) | Combined oxidative phosphorylation defect type 14 [RCV000693164]|not provided [RCV003144520] | likely benign|uncertain significance | 6 | 5368591 | 5368591 | Human | 1 | name |
| 15145993 | CV692013 | single nucleotide variant | NM_006567.5(FARS2):c.288C>T (p.His96=) | Combined oxidative phosphorylation defect type 14 [RCV000878474]|not provided [RCV003424430] | benign|likely benign | 6 | 5368858 | 5368858 | Human | 1 | name |
| 38489588 | CV924382 | single nucleotide variant | NM_006567.5(FARS2):c.17T>C (p.Leu6Pro) | Combined oxidative phosphorylation defect type 14 [RCV001221769] | uncertain significance | 6 | 5368587 | 5368587 | Human | 1 | name |
| 126760122 | CV1006711 | single nucleotide variant | NM_006567.5(FARS2):c.80A>G (p.His27Arg) | Combined oxidative phosphorylation defect type 14 [RCV001318251]|Inborn genetic diseases [RCV002543746] | uncertain significance | 6 | 5368650 | 5368650 | Human | 2 | name |
| 127268565 | CV1073713 | single nucleotide variant | NM_006567.5(FARS2):c.336C>T (p.Val112=) | Combined oxidative phosphorylation defect type 14 [RCV001404413] | likely benign | 6 | 5368906 | 5368906 | Human | 1 | name |
| 127259322 | CV1073714 | single nucleotide variant | NM_006567.5(FARS2):c.444G>T (p.Arg148=) | Combined oxidative phosphorylation defect type 14 [RCV001419764] | likely benign | 6 | 5369014 | 5369014 | Human | 1 | name |
| 127257902 | CV1073715 | single nucleotide variant | NM_006567.5(FARS2):c.450C>T (p.His150=) | Combined oxidative phosphorylation defect type 14 [RCV001401589] | likely benign | 6 | 5369020 | 5369020 | Human | 1 | name |
| 127233770 | CV1073716 | single nucleotide variant | NM_006567.5(FARS2):c.495C>T (p.His165=) | Combined oxidative phosphorylation defect type 14 [RCV001396261] | likely benign | 6 | 5369065 | 5369065 | Human | 1 | name |
| 127237215 | CV1073717 | single nucleotide variant | NM_006567.5(FARS2):c.549C>T (p.Ile183=) | Combined oxidative phosphorylation defect type 14 [RCV001414856] | likely benign | 6 | 5369119 | 5369119 | Human | 1 | name |
| 127263234 | CV1073718 | single nucleotide variant | NM_006567.5(FARS2):c.906T>G (p.Ala302=) | Combined oxidative phosphorylation defect type 14 [RCV001402945] | likely benign | 6 | 5545181 | 5545181 | Human | 1 | name |
| 127272892 | CV1095303 | single nucleotide variant | NM_006567.5(FARS2):c.378T>C (p.Phe126=) | Combined oxidative phosphorylation defect type 14 [RCV001442360] | likely benign | 6 | 5368948 | 5368948 | Human | 1 | name |
| 127241760 | CV1095304 | single nucleotide variant | NM_006567.5(FARS2):c.672T>C (p.Ser224=) | Combined oxidative phosphorylation defect type 14 [RCV001423615] | likely benign | 6 | 5404601 | 5404601 | Human | 1 | name |
| 127276329 | CV1095306 | single nucleotide variant | NM_006567.5(FARS2):c.924C>T (p.Ile308=) | Combined oxidative phosphorylation defect type 14 [RCV001443765] | likely benign | 6 | 5545199 | 5545199 | Human | 1 | name |
| 127274966 | CV1095307 | single nucleotide variant | NM_006567.5(FARS2):c.954G>A (p.Arg318=) | Combined oxidative phosphorylation defect type 14 [RCV001443106] | likely benign | 6 | 5545229 | 5545229 | Human | 1 | name |
| 127271468 | CV1095308 | single nucleotide variant | NM_006567.5(FARS2):c.972C>T (p.Tyr324=) | Combined oxidative phosphorylation defect type 14 [RCV001430971] | likely benign | 6 | 5545247 | 5545247 | Human | 1 | name |
| 127328460 | CV1116859 | single nucleotide variant | NM_006567.5(FARS2):c.774G>A (p.Glu258=) | Combined oxidative phosphorylation defect type 14 [RCV001469550] | likely benign | 6 | 5431042 | 5431042 | Human | 1 | name |
| 127322457 | CV1116860 | single nucleotide variant | NM_006567.5(FARS2):c.837C>T (p.Ile279=) | Combined oxidative phosphorylation defect type 14 [RCV001467591] | likely benign | 6 | 5431105 | 5431105 | Human | 1 | name |
| 127335516 | CV1116861 | single nucleotide variant | NM_006567.5(FARS2):c.957A>G (p.Leu319=) | Combined oxidative phosphorylation defect type 14 [RCV001474341] | likely benign | 6 | 5545232 | 5545232 | Human | 1 | name |
| 127311468 | CV1116862 | single nucleotide variant | NM_006567.5(FARS2):c.993C>G (p.Leu331=) | Combined oxidative phosphorylation defect type 14 [RCV001456905] | likely benign | 6 | 5545268 | 5545268 | Human | 1 | name |
| 127336640 | CV1137777 | single nucleotide variant | NM_006567.5(FARS2):c.318G>A (p.Gly106=) | Combined oxidative phosphorylation defect type 14 [RCV001492326]|not provided [RCV005256810] | likely benign | 6 | 5368888 | 5368888 | Human | 1 | name |
| 127295247 | CV1137778 | single nucleotide variant | NM_006567.5(FARS2):c.696C>T (p.Thr232=) | Combined oxidative phosphorylation defect type 14 [RCV001497220] | likely benign | 6 | 5404625 | 5404625 | Human | 1 | name |
| 127329028 | CV1137779 | single nucleotide variant | NM_006567.5(FARS2):c.775C>T (p.Leu259=) | Combined oxidative phosphorylation defect type 14 [RCV001487169] | likely benign | 6 | 5431043 | 5431043 | Human | 1 | name |
| 151783113 | CV1383629 | single nucleotide variant | NM_006567.5(FARS2):c.94T>A (p.Trp32Arg) | Combined oxidative phosphorylation defect type 14 [RCV001865147] | uncertain significance | 6 | 5368664 | 5368664 | Human | 1 | name |
| 151830252 | CV1384402 | single nucleotide variant | NM_006567.5(FARS2):c.955C>T (p.Leu319=) | Combined oxidative phosphorylation defect type 14 [RCV001955610]|not provided [RCV003490963] | likely benign|uncertain significance | 6 | 5545230 | 5545230 | Human | 1 | name |
| 8691033 | CV140992 | single nucleotide variant | NM_006567.5(FARS2):c.339C>T (p.Tyr113=) | Combined oxidative phosphorylation defect type 14 [RCV000532862]|not provided [RCV000677018]|not specified [RCV000124980] | benign | 6 | 5368909 | 5368909 | Human | 1 | name |
| 8691034 | CV140993 | single nucleotide variant | NM_006567.5(FARS2):c.606G>A (p.Lys202=) | Combined oxidative phosphorylation defect type 14 [RCV000560762]|not provided [RCV001171979]|not specified [RCV000124981] | benign|likely benign | 6 | 5369176 | 5369176 | Human | 1 | name |
| 151824629 | CV1466464 | single nucleotide variant | NM_006567.5(FARS2):c.28G>A (p.Ala10Thr) | Combined oxidative phosphorylation defect type 14 [RCV001879541] | uncertain significance | 6 | 5368598 | 5368598 | Human | 1 | name |
| 151879922 | CV1488581 | single nucleotide variant | NM_006567.5(FARS2):c.91G>A (p.Ala31Thr) | Combined oxidative phosphorylation defect type 14 [RCV001999401] | uncertain significance | 6 | 5368661 | 5368661 | Human | 1 | name |
| 151735497 | CV1508855 | single nucleotide variant | NM_006567.5(FARS2):c.86A>G (p.His29Arg) | Combined oxidative phosphorylation defect type 14 [RCV002021762] | uncertain significance | 6 | 5368656 | 5368656 | Human | 1 | name |
| 152073856 | CV1520793 | single nucleotide variant | NM_006567.5(FARS2):c.858G>A (p.Leu286=) | Combined oxidative phosphorylation defect type 14 [RCV002075463] | likely benign | 6 | 5431126 | 5431126 | Human | 1 | name |
| 152142174 | CV1526630 | single nucleotide variant | NM_006567.5(FARS2):c.312C>A (p.Arg104=) | Combined oxidative phosphorylation defect type 14 [RCV002084304] | likely benign | 6 | 5368882 | 5368882 | Human | 1 | name |
| 152143386 | CV1526833 | single nucleotide variant | NM_006567.5(FARS2):c.705C>T (p.Ala235=) | Combined oxidative phosphorylation defect type 14 [RCV002084462] | likely benign | 6 | 5404634 | 5404634 | Human | 1 | name |
| 152161223 | CV1534686 | single nucleotide variant | NM_006567.5(FARS2):c.894G>A (p.Leu298=) | Combined oxidative phosphorylation defect type 14 [RCV002140954] | likely benign | 6 | 5431162 | 5431162 | Human | 1 | name |
| 152158821 | CV1542102 | single nucleotide variant | NM_006567.5(FARS2):c.621T>G (p.Ala207=) | Combined oxidative phosphorylation defect type 14 [RCV002103400] | likely benign | 6 | 5404550 | 5404550 | Human | 1 | name |
| 152126255 | CV1565790 | single nucleotide variant | NM_006567.5(FARS2):c.372G>A (p.Gln124=) | Combined oxidative phosphorylation defect type 14 [RCV002136356] | likely benign | 6 | 5368942 | 5368942 | Human | 1 | name |
| 152033813 | CV1573067 | single nucleotide variant | NM_006567.5(FARS2):c.408C>T (p.Pro136=) | Combined oxidative phosphorylation defect type 14 [RCV002187156] | likely benign | 6 | 5368978 | 5368978 | Human | 1 | name |
| 152086215 | CV1589722 | single nucleotide variant | NM_006567.5(FARS2):c.933T>C (p.Ala311=) | Combined oxidative phosphorylation defect type 14 [RCV002193671] | likely benign | 6 | 5545208 | 5545208 | Human | 1 | name |
| 152171832 | CV1597826 | single nucleotide variant | NM_006567.5(FARS2):c.600C>T (p.Phe200=) | Combined oxidative phosphorylation defect type 14 [RCV002162249] | likely benign | 6 | 5369170 | 5369170 | Human | 1 | name |
| 152042085 | CV1603360 | single nucleotide variant | NM_006567.5(FARS2):c.735A>G (p.Gln245=) | Combined oxidative phosphorylation defect type 14 [RCV002071152] | likely benign | 6 | 5404664 | 5404664 | Human | 1 | name |
| 152161230 | CV1606125 | deletion | NM_006567.5(FARS2):c.1066-12_1066-11del | Combined oxidative phosphorylation defect type 14 [RCV002180969] | likely benign | 6 | 5613157 | 5613158 | Human | 1 | name |
| 152156352 | CV1615759 | single nucleotide variant | NM_006567.5(FARS2):c.342C>T (p.Asp114=) | Combined oxidative phosphorylation defect type 14 [RCV002158905] | likely benign | 6 | 5368912 | 5368912 | Human | 1 | name |
| 152150260 | CV1625722 | single nucleotide variant | NM_006567.5(FARS2):c.462G>A (p.Ala154=) | Combined oxidative phosphorylation defect type 14 [RCV002139408]|FARS2-related disorder [RCV003958792] | benign|likely benign | 6 | 5369032 | 5369032 | Human | 1 | name , trait , alternate_id |
| 152032237 | CV1643035 | single nucleotide variant | NM_006567.5(FARS2):c.375C>T (p.Asn125=) | Combined oxidative phosphorylation defect type 14 [RCV002204929] | likely benign | 6 | 5368945 | 5368945 | Human | 1 | name |
| 152052982 | CV1659234 | single nucleotide variant | NM_006567.5(FARS2):c.492G>A (p.Leu164=) | Combined oxidative phosphorylation defect type 14 [RCV002189636] | likely benign | 6 | 5369062 | 5369062 | Human | 1 | name |
| 152174829 | CV1663533 | single nucleotide variant | NM_006567.5(FARS2):c.852A>G (p.Glu284=) | Combined oxidative phosphorylation defect type 14 [RCV002144568] | likely benign | 6 | 5431120 | 5431120 | Human | 1 | name |
| 152103132 | CV1667388 | single nucleotide variant | NM_006567.5(FARS2):c.396A>G (p.Pro132=) | not provided [RCV002214375] | likely benign | 6 | 5368966 | 5368966 | Human | | name |
| 156415054 | CV1983157 | single nucleotide variant | NM_006567.5(FARS2):c.936T>C (p.Phe312=) | Combined oxidative phosphorylation defect type 14 [RCV002609490] | likely benign | 6 | 5545211 | 5545211 | Human | 1 | name |
| 156112560 | CV1988867 | single nucleotide variant | NM_006567.5(FARS2):c.876G>A (p.Gly292=) | Combined oxidative phosphorylation defect type 14 [RCV002622637] | likely benign | 6 | 5431144 | 5431144 | Human | 1 | name |
| 156226033 | CV1991524 | single nucleotide variant | NM_006567.5(FARS2):c.327G>A (p.Leu109=) | Combined oxidative phosphorylation defect type 14 [RCV002626620] | likely benign | 6 | 5368897 | 5368897 | Human | 1 | name |
| 156352369 | CV2015367 | single nucleotide variant | NM_006567.5(FARS2):c.300G>A (p.Gln100=) | Combined oxidative phosphorylation defect type 14 [RCV002720276] | likely benign | 6 | 5368870 | 5368870 | Human | 1 | name |
| 156198149 | CV2092370 | single nucleotide variant | NM_006567.5(FARS2):c.750C>T (p.Leu250=) | Combined oxidative phosphorylation defect type 14 [RCV002917690] | likely benign | 6 | 5404679 | 5404679 | Human | 1 | name |
| 156015195 | CV2120496 | single nucleotide variant | NM_006567.5(FARS2):c.738G>A (p.Thr246=) | Combined oxidative phosphorylation defect type 14 [RCV002975864] | likely benign | 6 | 5404667 | 5404667 | Human | 1 | name |
| 156211447 | CV2127762 | single nucleotide variant | NM_006567.5(FARS2):c.498G>A (p.Ala166=) | Combined oxidative phosphorylation defect type 14 [RCV002957761]|not provided [RCV004809874] | likely benign | 6 | 5369068 | 5369068 | Human | 1 | name |
| 156046380 | CV2144142 | single nucleotide variant | NM_006567.5(FARS2):c.474A>T (p.Ala158=) | Combined oxidative phosphorylation defect type 14 [RCV002999718] | likely benign | 6 | 5369044 | 5369044 | Human | 1 | name |
| 405013881 | CV2958739 | single nucleotide variant | NM_006567.5(FARS2):c.528T>C (p.Asp176=) | Combined oxidative phosphorylation defect type 14 [RCV003649605] | likely benign | 6 | 5369098 | 5369098 | Human | 1 | name |
| 405014277 | CV2970510 | single nucleotide variant | NM_006567.5(FARS2):c.513C>T (p.Phe171=) | Combined oxidative phosphorylation defect type 14 [RCV003649648] | likely benign | 6 | 5369083 | 5369083 | Human | 1 | name |
| 405014537 | CV2974326 | single nucleotide variant | NM_006567.5(FARS2):c.804C>T (p.Phe268=) | Combined oxidative phosphorylation defect type 14 [RCV003649675] | likely benign | 6 | 5431072 | 5431072 | Human | 1 | name |
| 405022000 | CV2980943 | single nucleotide variant | NM_006567.5(FARS2):c.768A>G (p.Gly256=) | Combined oxidative phosphorylation defect type 14 [RCV003650874] | likely benign | 6 | 5404697 | 5404697 | Human | 1 | name |
| 405035567 | CV3006410 | single nucleotide variant | NM_006567.5(FARS2):c.597C>G (p.Leu199=) | Combined oxidative phosphorylation defect type 14 [RCV003652670] | likely benign | 6 | 5369167 | 5369167 | Human | 1 | name |
| 405018809 | CV3052007 | single nucleotide variant | NM_006567.5(FARS2):c.726T>C (p.Asp242=) | Combined oxidative phosphorylation defect type 14 [RCV003650176] | likely benign | 6 | 5404655 | 5404655 | Human | 1 | name |
| 405025800 | CV3060302 | single nucleotide variant | NM_006567.5(FARS2):c.651C>G (p.Leu217=) | Combined oxidative phosphorylation defect type 14 [RCV003651356] | likely benign | 6 | 5404580 | 5404580 | Human | 1 | name |
| 405037525 | CV3070778 | single nucleotide variant | NM_006567.5(FARS2):c.555C>T (p.Ser185=) | Combined oxidative phosphorylation defect type 14 [RCV003652830] | likely benign | 6 | 5369125 | 5369125 | Human | 1 | name |
| 405040207 | CV3075262 | single nucleotide variant | NM_006567.5(FARS2):c.846T>C (p.His282=) | Combined oxidative phosphorylation defect type 14 [RCV003653125] | likely benign | 6 | 5431114 | 5431114 | Human | 1 | name |
| 405153860 | CV3163047 | single nucleotide variant | NM_006567.5(FARS2):c.486C>T (p.Asp162=) | Combined oxidative phosphorylation defect type 14 [RCV003856490] | likely benign | 6 | 5369056 | 5369056 | Human | 1 | name |
| 405202273 | CV3165058 | single nucleotide variant | NM_006567.5(FARS2):c.333G>C (p.Ser111=) | Combined oxidative phosphorylation defect type 14 [RCV003860919] | likely benign | 6 | 5368903 | 5368903 | Human | 1 | name |
| 597652340 | CV3672130 | single nucleotide variant | NM_006567.5(FARS2):c.88C>A (p.Gln30Lys) | Inborn genetic diseases [RCV004974861] | uncertain significance | 6 | 5368658 | 5368658 | Human | 1 | name |
| 12842052 | CV368681 | single nucleotide variant | NM_006567.5(FARS2):c.462G>T (p.Ala154=) | Combined oxidative phosphorylation defect type 14 [RCV000714918]|FARS2-related disorder [RCV003932585]|not provided [RCV001200284]|not specified [RCV000433710] | benign|likely benign | 6 | 5369032 | 5369032 | Human | 1 | name , trait , alternate_id |
| 12841688 | CV368687 | single nucleotide variant | NM_006567.5(FARS2):c.519G>C (p.Val173=) | Combined oxidative phosphorylation defect type 14 [RCV002524764]|not specified [RCV000433013] | benign|likely benign | 6 | 5369089 | 5369089 | Human | 1 | name |
| 12836060 | CV368988 | single nucleotide variant | NM_006567.5(FARS2):c.468G>A (p.Thr156=) | Combined oxidative phosphorylation defect type 14 [RCV000531369]|not provided [RCV005230320]|not specified [RCV000422752] | benign | 6 | 5369038 | 5369038 | Human | 1 | name |
| 12835123 | CV369157 | single nucleotide variant | NM_006567.5(FARS2):c.324G>A (p.Pro108=) | Combined oxidative phosphorylation defect type 14 [RCV000650600]|not provided [RCV001720242] | likely benign | 6 | 5368894 | 5368894 | Human | 1 | name |
| 12840802 | CV370501 | single nucleotide variant | NM_006567.5(FARS2):c.945A>G (p.Gly315=) | Combined oxidative phosphorylation defect type 14 [RCV000808579]|not specified [RCV000431399] | likely benign|uncertain significance | 6 | 5545220 | 5545220 | Human | 1 | name |
| 597957451 | CV3755079 | single nucleotide variant | NM_006567.5(FARS2):c.570T>C (p.Ile190=) | Combined oxidative phosphorylation defect type 14 [RCV005080749] | likely benign | 6 | 5369140 | 5369140 | Human | 1 | name |
| 597965801 | CV3793852 | single nucleotide variant | NM_006567.5(FARS2):c.891A>G (p.Gln297=) | Combined oxidative phosphorylation defect type 14 [RCV005140234] | likely benign | 6 | 5431159 | 5431159 | Human | 1 | name |
| 597863073 | CV3813579 | single nucleotide variant | NM_006567.5(FARS2):c.387G>A (p.Leu129=) | Combined oxidative phosphorylation defect type 14 [RCV005146841] | likely benign | 6 | 5368957 | 5368957 | Human | 1 | name |
| 597941103 | CV3819196 | single nucleotide variant | NM_006567.5(FARS2):c.798C>T (p.Cys266=) | Combined oxidative phosphorylation defect type 14 [RCV005159007] | likely benign | 6 | 5431066 | 5431066 | Human | 1 | name |
| 597976356 | CV3829574 | single nucleotide variant | NM_006567.5(FARS2):c.363G>A (p.Thr121=) | Combined oxidative phosphorylation defect type 14 [RCV005169841] | likely benign | 6 | 5368933 | 5368933 | Human | 1 | name |
| 598219217 | CV3895623 | duplication | NM_006567.5(FARS2):c.247dup (p.His83fs) | Leigh syndrome [RCV005360468] | likely pathogenic | 6 | 5368816 | 5368817 | Human | 1 | name |
| 13464599 | CV455856 | single nucleotide variant | NM_006567.5(FARS2):c.750C>A (p.Leu250=) | Combined oxidative phosphorylation defect type 14 [RCV000542297] | likely benign | 6 | 5404679 | 5404679 | Human | 1 | name |
| 13527020 | CV501381 | single nucleotide variant | NM_006567.5(FARS2):c.354A>G (p.Pro118=) | Combined oxidative phosphorylation defect type 14 [RCV000714915]|not specified [RCV000604903] | likely benign | 6 | 5368924 | 5368924 | Human | 1 | name |
| 13538278 | CV501770 | single nucleotide variant | NM_006567.5(FARS2):c.873C>T (p.Cys291=) | Combined oxidative phosphorylation defect type 14 [RCV000714928]|FARS2-related disorder [RCV003935707]|not specified [RCV000611599] | benign|likely benign | 6 | 5431141 | 5431141 | Human | 1 | name , trait , alternate_id |
| 13827688 | CV578606 | single nucleotide variant | NM_006567.5(FARS2):c.28G>T (p.Ala10Ser) | Combined oxidative phosphorylation defect type 14 [RCV000714912] | uncertain significance | 6 | 5368598 | 5368598 | Human | 1 | name |
| 13827691 | CV578610 | single nucleotide variant | NM_006567.5(FARS2):c.390C>A (p.Leu130=) | Combined oxidative phosphorylation defect type 14 [RCV000714916]|FARS2-related disorder [RCV003938057] | likely benign | 6 | 5368960 | 5368960 | Human | 1 | name , trait , alternate_id |
| 13827694 | CV578616 | single nucleotide variant | NM_006567.5(FARS2):c.585G>A (p.Glu195=) | Combined oxidative phosphorylation defect type 14 [RCV000714920] | uncertain significance | 6 | 5369155 | 5369155 | Human | 1 | name |
| 13827699 | CV578621 | single nucleotide variant | NM_006567.5(FARS2):c.768A>C (p.Gly256=) | Combined oxidative phosphorylation defect type 14 [RCV000714925] | benign|likely benign | 6 | 5404697 | 5404697 | Human | 1 | name |
| 13827700 | CV578622 | single nucleotide variant | NM_006567.5(FARS2):c.819T>A (p.Pro273=) | Combined oxidative phosphorylation defect type 14 [RCV000714926] | benign|likely benign | 6 | 5431087 | 5431087 | Human | 1 | name |
| 13827701 | CV578625 | single nucleotide variant | NM_006567.5(FARS2):c.984T>C (p.Asp328=) | Combined oxidative phosphorylation defect type 14 [RCV000714929]|FARS2-related disorder [RCV003953262] | likely benign | 6 | 5545259 | 5545259 | Human | 1 | name , trait , alternate_id |
| 15155542 | CV710563 | single nucleotide variant | NM_006567.5(FARS2):c.675G>A (p.Ala225=) | Combined oxidative phosphorylation defect type 14 [RCV000968943]|Inborn genetic diseases [RCV005338482] | likely benign | 6 | 5404604 | 5404604 | Human | 2 | name |
| 15186067 | CV722073 | single nucleotide variant | NM_006567.5(FARS2):c.588C>T (p.Ala196=) | Combined oxidative phosphorylation defect type 14 [RCV000886872]|not provided [RCV001815489] | likely benign | 6 | 5369158 | 5369158 | Human | 1 | name |
| 15164925 | CV750123 | single nucleotide variant | NM_006567.5(FARS2):c.909T>G (p.Gly303=) | not provided [RCV000926500] | likely benign | 6 | 5545184 | 5545184 | Human | | name |
| 15098394 | CV765744 | single nucleotide variant | NM_006567.5(FARS2):c.546G>A (p.Gln182=) | Combined oxidative phosphorylation defect type 14 [RCV001492321] | likely benign | 6 | 5369116 | 5369116 | Human | 1 | name |
| 26886664 | CV832065 | single nucleotide variant | NM_006567.5(FARS2):c.68T>A (p.Ile23Asn) | Combined oxidative phosphorylation defect type 14 [RCV001044374] | uncertain significance | 6 | 5368638 | 5368638 | Human | 1 | name |
| 38489742 | CV933365 | single nucleotide variant | NM_006567.5(FARS2):c.70T>A (p.Ser24Thr) | Combined oxidative phosphorylation defect type 14 [RCV001210330] | uncertain significance | 6 | 5368640 | 5368640 | Human | 1 | name |
| 38478053 | CV933367 | single nucleotide variant | NM_006567.5(FARS2):c.333G>A (p.Ser111=) | Combined oxidative phosphorylation defect type 14 [RCV001205371] | likely benign|uncertain significance | 6 | 5368903 | 5368903 | Human | 1 | name |
| 38475308 | CV933369 | single nucleotide variant | NM_006567.5(FARS2):c.786A>G (p.Arg262=) | Combined oxidative phosphorylation defect type 14 [RCV001204059] | likely benign|uncertain significance | 6 | 5431054 | 5431054 | Human | 1 | name |
| 126763410 | CV991563 | single nucleotide variant | NM_006567.5(FARS2):c.771T>C (p.Asp257=) | Combined oxidative phosphorylation defect type 14 [RCV001300688] | uncertain significance | 6 | 5404700 | 5404700 | Human | 1 | name |
| 126767904 | CV1006712 | single nucleotide variant | NM_006567.5(FARS2):c.183C>G (p.Asp61Glu) | Combined oxidative phosphorylation defect type 14 [RCV001321048] | uncertain significance | 6 | 5368753 | 5368753 | Human | 1 | name |
| 126912633 | CV1044191 | single nucleotide variant | NM_006567.5(FARS2):c.139C>T (p.Pro47Ser) | Combined oxidative phosphorylation defect type 14 [RCV001358890]|Inborn genetic diseases [RCV004034512] | uncertain significance | 6 | 5368709 | 5368709 | Human | 2 | name |
| 126924056 | CV1044192 | single nucleotide variant | NM_006567.5(FARS2):c.172T>C (p.Tyr58His) | Combined oxidative phosphorylation defect type 14 [RCV001366580] | uncertain significance | 6 | 5368742 | 5368742 | Human | 1 | name |
| 127258956 | CV1073719 | single nucleotide variant | NM_006567.5(FARS2):c.1044T>C (p.Ile348=) | Combined oxidative phosphorylation defect type 14 [RCV001419654] | likely benign | 6 | 5545319 | 5545319 | Human | 1 | name |
| 127278108 | CV1073807 | single nucleotide variant | NM_006567.5(FARS2):c.1251G>A (p.Thr417=) | Combined oxidative phosphorylation defect type 14 [RCV001408282] | likely benign | 6 | 5771324 | 5771324 | Human | 1 | name |
| 127270893 | CV1095391 | single nucleotide variant | NM_006567.5(FARS2):c.1230C>T (p.Thr410=) | Combined oxidative phosphorylation defect type 14 [RCV001430763] | likely benign | 6 | 5771303 | 5771303 | Human | 1 | name |
| 127300617 | CV1116863 | single nucleotide variant | NM_006567.5(FARS2):c.1041C>T (p.Asn347=) | Combined oxidative phosphorylation defect type 14 [RCV001478449] | likely benign | 6 | 5545316 | 5545316 | Human | 1 | name |
| 127315227 | CV1116864 | single nucleotide variant | NM_006567.5(FARS2):c.1116C>T (p.Pro372=) | Combined oxidative phosphorylation defect type 14 [RCV001465168] | likely benign | 6 | 5613219 | 5613219 | Human | 1 | name |
| 127291237 | CV1116948 | single nucleotide variant | NM_006567.5(FARS2):c.1221G>A (p.Thr407=) | Combined oxidative phosphorylation defect type 14 [RCV001458658] | likely benign | 6 | 5771294 | 5771294 | Human | 1 | name |
| 127290514 | CV1137781 | single nucleotide variant | NM_006567.5(FARS2):c.1011G>A (p.Glu337=) | Combined oxidative phosphorylation defect type 14 [RCV001495996] | likely benign | 6 | 5545286 | 5545286 | Human | 1 | name |
| 151724971 | CV1351030 | single nucleotide variant | NM_006567.5(FARS2):c.131A>G (p.Gln44Arg) | Combined oxidative phosphorylation defect type 14 [RCV001891602] | uncertain significance | 6 | 5368701 | 5368701 | Human | 1 | name |
| 151826058 | CV1392201 | deletion | NM_006567.5(FARS2):c.425del (p.Asp142fs) | Combined oxidative phosphorylation defect type 14 [RCV001879665] | pathogenic | 6 | 5368995 | 5368995 | Human | 1 | name |
| 151751619 | CV1407036 | single nucleotide variant | NM_006567.5(FARS2):c.184G>T (p.Asp62Tyr) | Combined oxidative phosphorylation defect type 14 [RCV002023434] | uncertain significance | 6 | 5368754 | 5368754 | Human | 1 | name |
| 151841709 | CV1423811 | single nucleotide variant | NM_006567.5(FARS2):c.146G>A (p.Ser49Asn) | Combined oxidative phosphorylation defect type 14 [RCV001977776] | uncertain significance | 6 | 5368716 | 5368716 | Human | 1 | name |
| 151840552 | CV1432087 | deletion | NM_006567.5(FARS2):c.694del (p.Thr232fs) | Combined oxidative phosphorylation defect type 14 [RCV001994687] | pathogenic | 6 | 5404623 | 5404623 | Human | 1 | name |
| 151724485 | CV1455461 | single nucleotide variant | NM_006567.5(FARS2):c.259T>G (p.Trp87Gly) | Combined oxidative phosphorylation defect type 14 [RCV002020609] | uncertain significance | 6 | 5368829 | 5368829 | Human | 1 | name |
| 151873011 | CV1499362 | single nucleotide variant | NM_006567.5(FARS2):c.184G>A (p.Asp62Asn) | Combined oxidative phosphorylation defect type 14 [RCV001885513] | uncertain significance | 6 | 5368754 | 5368754 | Human | 1 | name |
| 151744935 | CV1501600 | single nucleotide variant | NM_006567.5(FARS2):c.297G>T (p.Lys99Asn) | Combined oxidative phosphorylation defect type 14 [RCV002042626] | uncertain significance | 6 | 5368867 | 5368867 | Human | 1 | name |
| 151888483 | CV1517133 | single nucleotide variant | NM_006567.5(FARS2):c.224G>T (p.Gly75Val) | Combined oxidative phosphorylation defect type 14 [RCV002038410] | uncertain significance | 6 | 5368794 | 5368794 | Human | 1 | name |
| 152126071 | CV1620429 | single nucleotide variant | NM_006567.5(FARS2):c.1200C>T (p.Asp400=) | Combined oxidative phosphorylation defect type 14 [RCV002098839] | likely benign | 6 | 5613303 | 5613303 | Human | 1 | name |
| 152123667 | CV1641160 | single nucleotide variant | NM_006567.5(FARS2):c.1293G>A (p.Arg431=) | Combined oxidative phosphorylation defect type 14 [RCV002098509] | likely benign | 6 | 5771366 | 5771366 | Human | 1 | name |
| 155709136 | CV1773374 | single nucleotide variant | NM_006567.5(FARS2):c.296A>G (p.Lys99Arg) | Combined oxidative phosphorylation defect type 14 [RCV002297086] | uncertain significance | 6 | 5368866 | 5368866 | Human | 1 | name |
| 156026102 | CV1918762 | single nucleotide variant | NM_006567.5(FARS2):c.261G>C (p.Trp87Cys) | Combined oxidative phosphorylation defect type 14 [RCV002636951] | uncertain significance | 6 | 5368831 | 5368831 | Human | 1 | name |
| 155964018 | CV1931810 | single nucleotide variant | NM_006567.5(FARS2):c.284A>G (p.Glu95Gly) | Combined oxidative phosphorylation defect type 14 [RCV002616869] | uncertain significance | 6 | 5368854 | 5368854 | Human | 1 | name |
| 156336423 | CV1997206 | single nucleotide variant | NM_006567.5(FARS2):c.206A>G (p.Lys69Arg) | Combined oxidative phosphorylation defect type 14 [RCV002650094]|Inborn genetic diseases [RCV005343451] | uncertain significance | 6 | 5368776 | 5368776 | Human | 2 | name |
| 156306921 | CV1999880 | single nucleotide variant | NM_006567.5(FARS2):c.113C>A (p.Ala38Glu) | Combined oxidative phosphorylation defect type 14 [RCV002671426] | uncertain significance | 6 | 5368683 | 5368683 | Human | 1 | name |
| 156349604 | CV2001117 | single nucleotide variant | NM_006567.5(FARS2):c.1218G>A (p.Lys406=) | Combined oxidative phosphorylation defect type 14 [RCV002675497] | uncertain significance | 6 | 5771291 | 5771291 | Human | 1 | name |
| 156172540 | CV2016209 | single nucleotide variant | NM_006567.5(FARS2):c.125C>T (p.Ala42Val) | Combined oxidative phosphorylation defect type 14 [RCV002710525] | uncertain significance | 6 | 5368695 | 5368695 | Human | 1 | name |
| 156135458 | CV2022926 | single nucleotide variant | NM_006567.5(FARS2):c.1092C>T (p.Ile364=) | Combined oxidative phosphorylation defect type 14 [RCV002740713] | likely benign | 6 | 5613195 | 5613195 | Human | 1 | name |
| 10411168 | CV211247 | single nucleotide variant | NM_006567.5(FARS2):c.101C>T (p.Ser34Leu) | Combined oxidative phosphorylation defect type 14 [RCV000541416]|not provided [RCV003480548] | likely benign|uncertain significance | 6 | 5368671 | 5368671 | Human | 1 | name |
| 10409436 | CV211248 | single nucleotide variant | NM_006567.5(FARS2):c.170C>G (p.Ser57Cys) | Combined oxidative phosphorylation defect type 14 [RCV000539812]|not provided [RCV004705026]|not specified [RCV000196113] | benign|likely benign | 6 | 5368740 | 5368740 | Human | 1 | name |
| 156196199 | CV2113687 | single nucleotide variant | NM_006567.5(FARS2):c.151G>C (p.Val51Leu) | Combined oxidative phosphorylation defect type 14 [RCV002957220] | uncertain significance | 6 | 5368721 | 5368721 | Human | 1 | name |
| 156026447 | CV2145719 | duplication | NM_006567.5(FARS2):c.497dup (p.Leu168fs) | Combined oxidative phosphorylation defect type 14 [RCV003018482] | pathogenic | 6 | 5369066 | 5369067 | Human | 1 | name |
| 156360015 | CV2162424 | single nucleotide variant | NM_006567.5(FARS2):c.178C>T (p.Gln60Ter) | Combined oxidative phosphorylation defect type 14 [RCV003031498] | pathogenic | 6 | 5368748 | 5368748 | Human | 1 | name |
| 401796921 | CV2739922 | single nucleotide variant | NM_006567.5(FARS2):c.187C>A (p.His63Asn) | not provided [RCV003319883] | uncertain significance | 6 | 5368757 | 5368757 | Human | | name |
| 405148882 | CV2933442 | indel | NM_006567.5(FARS2):c.1218-73_1289delinsC | Combined oxidative phosphorylation defect type 14 [RCV003538295] | pathogenic | 6 | 5771218 | 5771362 | Human | | name |
| 405036085 | CV3013609 | single nucleotide variant | NM_006567.5(FARS2):c.1267C>A (p.Arg423=) | Combined oxidative phosphorylation defect type 14 [RCV003652728] | likely benign | 6 | 5771340 | 5771340 | Human | 1 | name |
| 597652334 | CV3672129 | single nucleotide variant | NM_006567.5(FARS2):c.106C>T (p.Pro36Ser) | Inborn genetic diseases [RCV004974860] | uncertain significance | 6 | 5368676 | 5368676 | Human | 1 | name |
| 12835822 | CV369007 | single nucleotide variant | NM_006567.5(FARS2):c.1344G>A (p.Glu448=) | Combined oxidative phosphorylation defect type 14 [RCV000714937]|not specified [RCV000422351] | likely benign | 6 | 5771417 | 5771417 | Human | 1 | name |
| 12843849 | CV370502 | single nucleotide variant | NM_006567.5(FARS2):c.1059G>A (p.Lys353=) | not specified [RCV000436965] | likely benign | 6 | 5545334 | 5545334 | Human | | name |
| 597896556 | CV3782255 | single nucleotide variant | NM_006567.5(FARS2):c.1355G>A (p.Ter452=) | Combined oxidative phosphorylation defect type 14 [RCV005126480] | likely benign | 6 | 5771428 | 5771428 | Human | 1 | name |
| 597939818 | CV3788634 | single nucleotide variant | NM_006567.5(FARS2):c.1251G>C (p.Thr417=) | Combined oxidative phosphorylation defect type 14 [RCV005133309] | likely benign | 6 | 5771324 | 5771324 | Human | 1 | name |
| 597973740 | CV3801557 | single nucleotide variant | NM_006567.5(FARS2):c.1341G>A (p.Val447=) | Combined oxidative phosphorylation defect type 14 [RCV005143546] | likely benign | 6 | 5771414 | 5771414 | Human | 1 | name |
| 597909839 | CV3806508 | single nucleotide variant | NM_006567.5(FARS2):c.167A>T (p.Lys56Ile) | Combined oxidative phosphorylation defect type 14 [RCV005154075] | uncertain significance | 6 | 5368737 | 5368737 | Human | 1 | name |
| 13482667 | CV455894 | single nucleotide variant | NM_006567.5(FARS2):c.1308C>G (p.Ala436=) | Combined oxidative phosphorylation defect type 14 [RCV000529517]|not provided [RCV001530767] | likely benign | 6 | 5771381 | 5771381 | Human | 1 | name |
| 13499576 | CV456590 | single nucleotide variant | NM_006567.5(FARS2):c.1209A>G (p.Val403=) | Combined oxidative phosphorylation defect type 14 [RCV000539910] | likely benign | 6 | 5613312 | 5613312 | Human | 1 | name |
| 13508719 | CV481383 | single nucleotide variant | NM_006567.5(FARS2):c.192C>G (p.Ser64Arg) | Combined oxidative phosphorylation defect type 14 [RCV000578287] | likely pathogenic | 6 | 5368762 | 5368762 | Human | 1 | name |
| 13541394 | CV501674 | single nucleotide variant | NM_006567.5(FARS2):c.1128C>T (p.Tyr376=) | Combined oxidative phosphorylation defect type 14 [RCV000877860]|not provided [RCV001722604] | likely benign | 6 | 5613231 | 5613231 | Human | 1 | name |
| 13812004 | CV560904 | deletion | NM_006567.5(FARS2):c.792del (p.Asp265fs) | Combined oxidative phosphorylation defect type 14 [RCV000703415]|FARS2-related disorder [RCV004547874]|Hereditary spastic paraplegia 77 [RCV003994089]|Inborn genetic diseases [RCV002534412]|Leigh syndrome [RCV005357940]|not provided [RCV001009136] | pathogenic|likely pathogenic|uncertain significance | 6 | 5431060 | 5431060 | Human | 4 | name , trait , alternate_id |
| 13827709 | CV578607 | single nucleotide variant | NM_006567.5(FARS2):c.253C>G (p.Pro85Ala) | Combined oxidative phosphorylation defect type 14 [RCV000714938] | likely pathogenic|conflicting interpretations of pathogenicity | 6 | 5368823 | 5368823 | Human | 1 | name |
| 13827702 | CV578626 | single nucleotide variant | NM_006567.5(FARS2):c.1014C>T (p.Arg338=) | Combined oxidative phosphorylation defect type 14 [RCV000714930]|FARS2-related disorder [RCV003918155] | benign|likely benign | 6 | 5545289 | 5545289 | Human | 1 | name , trait , alternate_id |
| 13827705 | CV578630 | single nucleotide variant | NM_006567.5(FARS2):c.1083G>A (p.Pro361=) | Combined oxidative phosphorylation defect type 14 [RCV000714933] | likely benign | 6 | 5613186 | 5613186 | Human | 1 | name |
| 13827708 | CV578634 | single nucleotide variant | NM_006567.5(FARS2):c.1296C>T (p.His432=) | Combined oxidative phosphorylation defect type 14 [RCV000714936] | likely benign | 6 | 5771369 | 5771369 | Human | 1 | name |
| 14707273 | CV635003 | single nucleotide variant | NM_006567.5(FARS2):c.128C>G (p.Thr43Ser) | Combined oxidative phosphorylation defect type 14 [RCV000808731]|Inborn genetic diseases [RCV003258984]|not provided [RCV003106070] | uncertain significance | 6 | 5368698 | 5368698 | Human | 2 | name |
| 14704600 | CV635004 | single nucleotide variant | NM_006567.5(FARS2):c.261G>A (p.Trp87Ter) | Combined oxidative phosphorylation defect type 14 [RCV000807810] | pathogenic | 6 | 5368831 | 5368831 | Human | 1 | name |
| 14708741 | CV635009 | deletion | NM_006567.5(FARS2):c.812del (p.Thr271fs) | Combined oxidative phosphorylation defect type 14 [RCV000810202] | pathogenic | 6 | 5431080 | 5431080 | Human | 1 | name |
| 15175452 | CV699637 | single nucleotide variant | NM_006567.5(FARS2):c.1273C>T (p.Leu425=) | Combined oxidative phosphorylation defect type 14 [RCV000950584] | likely benign | 6 | 5771346 | 5771346 | Human | 1 | name |
| 15170495 | CV710567 | single nucleotide variant | NM_006567.5(FARS2):c.1008C>T (p.Asp336=) | Combined oxidative phosphorylation defect type 14 [RCV001481322] | likely benign | 6 | 5545283 | 5545283 | Human | 1 | name |
| 26916299 | CV832066 | single nucleotide variant | NM_006567.5(FARS2):c.202C>T (p.Arg68Trp) | Combined oxidative phosphorylation defect type 14 [RCV001056273]|Inborn genetic diseases [RCV004977946] | uncertain significance | 6 | 5368772 | 5368772 | Human | 2 | name |
| 26920838 | CV832067 | single nucleotide variant | NM_006567.5(FARS2):c.267C>G (p.Ile89Met) | Combined oxidative phosphorylation defect type 14 [RCV001060389]|Inborn genetic diseases [RCV002553881]|not provided [RCV005250131] | likely benign|uncertain significance | 6 | 5368837 | 5368837 | Human | 2 | name |
| 38485223 | CV924415 | single nucleotide variant | NM_006567.5(FARS2):c.1269G>T (p.Arg423=) | Combined oxidative phosphorylation defect type 14 [RCV001219499] | likely benign|uncertain significance | 6 | 5771342 | 5771342 | Human | 1 | name |
| 38489100 | CV933366 | single nucleotide variant | NM_006567.5(FARS2):c.230A>T (p.Asn77Ile) | Combined oxidative phosphorylation defect type 14 [RCV001210053] | uncertain significance | 6 | 5368800 | 5368800 | Human | 1 | name |
| 38486317 | CV945072 | single nucleotide variant | NM_006567.5(FARS2):c.120G>T (p.Glu40Asp) | Combined oxidative phosphorylation defect type 14 [RCV001237157] | uncertain significance | 6 | 5368690 | 5368690 | Human | 1 | name |
| 38465947 | CV962036 | single nucleotide variant | NM_006567.5(FARS2):c.251A>C (p.His84Pro) | Combined oxidative phosphorylation defect type 14 [RCV001250396] | pathogenic | 6 | 5368821 | 5368821 | Human | 1 | name |
| 126756443 | CV991558 | single nucleotide variant | NM_006567.5(FARS2):c.203G>A (p.Arg68Gln) | Combined oxidative phosphorylation defect type 14 [RCV001308113] | uncertain significance | 6 | 5368773 | 5368773 | Human | 1 | name |
| 126763909 | CV1006713 | single nucleotide variant | NM_006567.5(FARS2):c.586G>T (p.Ala196Ser) | Combined oxidative phosphorylation defect type 14 [RCV001319429] | uncertain significance | 6 | 5369156 | 5369156 | Human | 1 | name |
| 126771870 | CV1006714 | single nucleotide variant | NM_006567.5(FARS2):c.630G>C (p.Lys210Asn) | Combined oxidative phosphorylation defect type 14 [RCV001323408] | uncertain significance | 6 | 5404559 | 5404559 | Human | 1 | name |
| 126740842 | CV1006715 | single nucleotide variant | NM_006567.5(FARS2):c.755C>G (p.Ala252Gly) | Combined oxidative phosphorylation defect type 14 [RCV001314438] | uncertain significance | 6 | 5404684 | 5404684 | Human | 1 | name |
| 126772784 | CV1006716 | single nucleotide variant | NM_006567.5(FARS2):c.920G>A (p.Arg307Gln) | Combined oxidative phosphorylation defect type 14 [RCV001323956] | uncertain significance | 6 | 5545195 | 5545195 | Human | 1 | name |
| 126730870 | CV1020281 | single nucleotide variant | NM_006567.5(FARS2):c.988C>A (p.Arg330Ser) | Combined oxidative phosphorylation defect type 14 [RCV001333555] | uncertain significance | 6 | 5545263 | 5545263 | Human | 1 | name |
| 126767121 | CV1027258 | single nucleotide variant | NM_006567.5(FARS2):c.364A>G (p.Thr122Ala) | Combined oxidative phosphorylation defect type 14 [RCV001342696] | uncertain significance | 6 | 5368934 | 5368934 | Human | 1 | name |
| 126733571 | CV1027259 | single nucleotide variant | NM_006567.5(FARS2):c.477C>A (p.His159Gln) | Combined oxidative phosphorylation defect type 14 [RCV001349804] | uncertain significance | 6 | 5369047 | 5369047 | Human | 1 | name |
| 126920820 | CV1044193 | single nucleotide variant | NM_006567.5(FARS2):c.308G>T (p.Gly103Val) | Combined oxidative phosphorylation defect type 14 [RCV001374033] | uncertain significance | 6 | 5368878 | 5368878 | Human | 1 | name |
| 126917387 | CV1044194 | single nucleotide variant | NM_006567.5(FARS2):c.362C>T (p.Thr121Met) | Combined oxidative phosphorylation defect type 14 [RCV001361138]|not provided [RCV004774427] | uncertain significance | 6 | 5368932 | 5368932 | Human | 1 | name |
| 126912990 | CV1044196 | single nucleotide variant | NM_006567.5(FARS2):c.997T>A (p.Trp333Arg) | Combined oxidative phosphorylation defect type 14 [RCV001359008] | uncertain significance | 6 | 5545272 | 5545272 | Human | 1 | name |
| 127262790 | CV1060771 | single nucleotide variant | NM_006567.5(FARS2):c.298C>T (p.Gln100Ter) | Combined oxidative phosphorylation defect type 14 [RCV001380811]|Inborn genetic diseases [RCV003246964] | pathogenic | 6 | 5368868 | 5368868 | Human | 2 | name |
| 151235731 | CV1318997 | single nucleotide variant | NM_006567.5(FARS2):c.634G>A (p.Gly212Arg) | Combined oxidative phosphorylation defect type 14 [RCV001795813]|not provided [RCV005428420] | uncertain significance | 6 | 5404563 | 5404563 | Human | 1 | name |
| 151728583 | CV1338932 | single nucleotide variant | NM_006567.5(FARS2):c.515T>C (p.Leu172Pro) | Combined oxidative phosphorylation defect type 14 [RCV002004541]|Combined oxidative phosphorylation defect type 14 [RCV002492096] | uncertain significance | 6 | 5369085 | 5369085 | Human | 2 | name |
| 151798657 | CV1347353 | single nucleotide variant | NM_006567.5(FARS2):c.424G>A (p.Asp142Asn) | Combined oxidative phosphorylation defect type 14 [RCV002027885] | likely pathogenic | 6 | 5368994 | 5368994 | Human | 1 | name |
| 151829363 | CV1348431 | single nucleotide variant | NM_006567.5(FARS2):c.916G>T (p.Asp306Tyr) | Combined oxidative phosphorylation defect type 14 [RCV001870381] | uncertain significance | 6 | 5545191 | 5545191 | Human | 1 | name |
| 151849971 | CV1355264 | single nucleotide variant | NM_006567.5(FARS2):c.852A>C (p.Glu284Asp) | Combined oxidative phosphorylation defect type 14 [RCV001957846] | uncertain significance | 6 | 5431120 | 5431120 | Human | 1 | name |
| 151759090 | CV1361677 | single nucleotide variant | NM_006567.5(FARS2):c.443G>A (p.Arg148Gln) | Combined oxidative phosphorylation defect type 14 [RCV001928298]|not provided [RCV003319491] | uncertain significance | 6 | 5369013 | 5369013 | Human | 1 | name |
| 151821298 | CV1388913 | single nucleotide variant | NM_006567.5(FARS2):c.626T>C (p.Ile209Thr) | Combined oxidative phosphorylation defect type 14 [RCV001975755] | uncertain significance | 6 | 5404555 | 5404555 | Human | 1 | name |
| 151827844 | CV1395773 | single nucleotide variant | NM_006567.5(FARS2):c.441T>A (p.Asn147Lys) | Combined oxidative phosphorylation defect type 14 [RCV002050424] | uncertain significance | 6 | 5369011 | 5369011 | Human | 1 | name |
| 8691035 | CV140994 | single nucleotide variant | NM_006567.5(FARS2):c.737C>T (p.Thr246Met) | Combined oxidative phosphorylation defect type 14 [RCV000527403]|not provided [RCV000677019]|not specified [RCV000124982] | benign|likely benign|uncertain significance | 6 | 5404666 | 5404666 | Human | 1 | name |
| 8691036 | CV140995 | single nucleotide variant | NM_006567.5(FARS2):c.839A>G (p.Asn280Ser) | Combined oxidative phosphorylation defect type 14 [RCV000714927]|Hereditary spastic paraplegia 77 [RCV001701760]|not provided [RCV000677020]|not specified [RCV000124983] | benign | 6 | 5431107 | 5431107 | Human | 2 | name |
| 151788705 | CV1413077 | single nucleotide variant | NM_006567.5(FARS2):c.985A>G (p.Ile329Val) | Combined oxidative phosphorylation defect type 14 [RCV001989862] | uncertain significance | 6 | 5545260 | 5545260 | Human | 1 | name |
| 151846341 | CV1431496 | single nucleotide variant | NM_006567.5(FARS2):c.539G>A (p.Arg180His) | Combined oxidative phosphorylation defect type 14 [RCV001957378] | uncertain significance | 6 | 5369109 | 5369109 | Human | 1 | name |
| 151845623 | CV1437766 | single nucleotide variant | NM_006567.5(FARS2):c.562T>C (p.Tyr188His) | Combined oxidative phosphorylation defect type 14 [RCV001903388] | uncertain significance | 6 | 5369132 | 5369132 | Human | 1 | name |
| 151730153 | CV1441120 | single nucleotide variant | NM_006567.5(FARS2):c.704C>T (p.Ala235Val) | Combined oxidative phosphorylation defect type 14 [RCV001945956] | uncertain significance | 6 | 5404633 | 5404633 | Human | 1 | name |
| 151780034 | CV1446207 | single nucleotide variant | NM_006567.5(FARS2):c.425A>G (p.Asp142Gly) | Combined oxidative phosphorylation defect type 14 [RCV001989047] | likely pathogenic | 6 | 5368995 | 5368995 | Human | 1 | name |
| 151844276 | CV1457793 | single nucleotide variant | NM_006567.5(FARS2):c.955C>A (p.Leu319Ile) | Combined oxidative phosphorylation defect type 14 [RCV001936497]|Inborn genetic diseases [RCV002560612] | uncertain significance | 6 | 5545230 | 5545230 | Human | 2 | name |
| 151826871 | CV1471814 | single nucleotide variant | NM_006567.5(FARS2):c.698T>C (p.Met233Thr) | Combined oxidative phosphorylation defect type 14 [RCV002030413] | uncertain significance | 6 | 5404627 | 5404627 | Human | 1 | name |
| 151887314 | CV1471947 | single nucleotide variant | NM_006567.5(FARS2):c.407C>T (p.Pro136Leu) | Combined oxidative phosphorylation defect type 14 [RCV002000858] | uncertain significance | 6 | 5368977 | 5368977 | Human | 1 | name |
| 151791804 | CV1486273 | single nucleotide variant | NM_006567.5(FARS2):c.999G>A (p.Trp333Ter) | Combined oxidative phosphorylation defect type 14 [RCV002047179] | pathogenic | 6 | 5545274 | 5545274 | Human | 1 | name |
| 151791817 | CV1490042 | single nucleotide variant | NM_006567.5(FARS2):c.668G>C (p.Arg223Pro) | Combined oxidative phosphorylation defect type 14 [RCV001952121] | uncertain significance | 6 | 5404597 | 5404597 | Human | 1 | name |
| 151878288 | CV1493722 | single nucleotide variant | NM_006567.5(FARS2):c.592C>T (p.Arg198Trp) | Combined oxidative phosphorylation defect type 14 [RCV001982182] | uncertain significance | 6 | 5369162 | 5369162 | Human | 1 | name |
| 151814223 | CV1494804 | single nucleotide variant | NM_006567.5(FARS2):c.409A>G (p.Ser137Gly) | Combined oxidative phosphorylation defect type 14 [RCV001954122]|Inborn genetic diseases [RCV002569165] | uncertain significance | 6 | 5368979 | 5368979 | Human | 2 | name |
| 151759669 | CV1500828 | single nucleotide variant | NM_006567.5(FARS2):c.382A>G (p.Ser128Gly) | Combined oxidative phosphorylation defect type 14 [RCV001987116] | uncertain significance | 6 | 5368952 | 5368952 | Human | 1 | name |
| 151723699 | CV1507740 | single nucleotide variant | NM_006567.5(FARS2):c.815A>C (p.His272Pro) | Combined oxidative phosphorylation defect type 14 [RCV001983417] | uncertain significance | 6 | 5431083 | 5431083 | Human | 1 | name |
| 151752172 | CV1508495 | single nucleotide variant | NM_006567.5(FARS2):c.700G>A (p.Glu234Lys) | Combined oxidative phosphorylation defect type 14 [RCV001986398]|Inborn genetic diseases [RCV002608047] | uncertain significance | 6 | 5404629 | 5404629 | Human | 2 | name |
| 151865268 | CV1509764 | single nucleotide variant | NM_006567.5(FARS2):c.308G>C (p.Gly103Ala) | Combined oxidative phosphorylation defect type 14 [RCV001924521] | uncertain significance | 6 | 5368878 | 5368878 | Human | 1 | name |
| 151792401 | CV1515582 | single nucleotide variant | NM_006567.5(FARS2):c.589G>A (p.Val197Met) | Combined oxidative phosphorylation defect type 14 [RCV002027348]|not specified [RCV004782861] | pathogenic|likely pathogenic|uncertain significance | 6 | 5369159 | 5369159 | Human | 1 | name |
| 151870457 | CV1515616 | single nucleotide variant | NM_006567.5(FARS2):c.907G>A (p.Gly303Ser) | Combined oxidative phosphorylation defect type 14 [RCV001981228]|Inborn genetic diseases [RCV003250389] | uncertain significance | 6 | 5545182 | 5545182 | Human | 2 | name |
| 156287188 | CV1907490 | single nucleotide variant | NM_006567.5(FARS2):c.453G>A (p.Met151Ile) | Combined oxidative phosphorylation defect type 14 [RCV003087331] | uncertain significance | 6 | 5369023 | 5369023 | Human | 1 | name |
| 156042622 | CV1999090 | single nucleotide variant | NM_006567.5(FARS2):c.929G>A (p.Trp310Ter) | Combined oxidative phosphorylation defect type 14 [RCV002659096] | pathogenic | 6 | 5545204 | 5545204 | Human | 1 | name |
| 156370653 | CV2007710 | single nucleotide variant | NM_006567.5(FARS2):c.631G>A (p.Asp211Asn) | Combined oxidative phosphorylation defect type 14 [RCV002676870] | uncertain significance | 6 | 5404560 | 5404560 | Human | 1 | name |
| 156367066 | CV2010831 | single nucleotide variant | NM_006567.5(FARS2):c.902C>T (p.Ser301Leu) | Combined oxidative phosphorylation defect type 14 [RCV002676637]|FARS2-related disorder [RCV003403885] | uncertain significance | 6 | 5431170 | 5431170 | Human | 1 | name , trait , alternate_id |
| 156281903 | CV2016383 | single nucleotide variant | NM_006567.5(FARS2):c.317G>T (p.Gly106Val) | Combined oxidative phosphorylation defect type 14 [RCV002715328] | uncertain significance | 6 | 5368887 | 5368887 | Human | 1 | name |
| 156183707 | CV2020588 | single nucleotide variant | NM_006567.5(FARS2):c.922A>G (p.Ile308Val) | Combined oxidative phosphorylation defect type 14 [RCV002710862] | uncertain significance | 6 | 5545197 | 5545197 | Human | 1 | name |
| 156080838 | CV2022784 | single nucleotide variant | NM_006567.5(FARS2):c.835A>G (p.Ile279Val) | Combined oxidative phosphorylation defect type 14 [RCV002760619] | benign | 6 | 5431103 | 5431103 | Human | 1 | name |
| 156372187 | CV2028170 | single nucleotide variant | NM_006567.5(FARS2):c.508G>A (p.Ala170Thr) | Combined oxidative phosphorylation defect type 14 [RCV002721610] | uncertain significance | 6 | 5369078 | 5369078 | Human | 1 | name |
| 156012785 | CV2042136 | single nucleotide variant | NM_006567.5(FARS2):c.311G>A (p.Arg104His) | Combined oxidative phosphorylation defect type 14 [RCV002780235] | uncertain significance | 6 | 5368881 | 5368881 | Human | 1 | name |
| 156374017 | CV2052857 | single nucleotide variant | NM_006567.5(FARS2):c.619G>T (p.Ala207Ser) | Combined oxidative phosphorylation defect type 14 [RCV002814537] | uncertain significance | 6 | 5404548 | 5404548 | Human | 1 | name |
| 155921051 | CV2073707 | single nucleotide variant | NM_006567.5(FARS2):c.445A>T (p.Thr149Ser) | Combined oxidative phosphorylation defect type 14 [RCV002838319] | uncertain significance | 6 | 5369015 | 5369015 | Human | 1 | name |
| 156040034 | CV2094074 | single nucleotide variant | NM_006567.5(FARS2):c.389T>G (p.Leu130Arg) | Combined oxidative phosphorylation defect type 14 [RCV002885776] | uncertain significance | 6 | 5368959 | 5368959 | Human | 1 | name |
| 10411231 | CV211249 | single nucleotide variant | NM_006567.5(FARS2):c.323C>T (p.Pro108Leu) | Combined oxidative phosphorylation defect type 14 [RCV000807526]|Inborn genetic diseases [RCV002517210] | likely pathogenic|uncertain significance | 6 | 5368893 | 5368893 | Human | 2 | name |
| 10410068 | CV211250 | single nucleotide variant | NM_006567.5(FARS2):c.403C>G (p.His135Asp) | Combined oxidative phosphorylation defect type 14 [RCV000714939] | likely pathogenic | 6 | 5368973 | 5368973 | Human | 1 | name |
| 10410338 | CV211251 | single nucleotide variant | NM_006567.5(FARS2):c.496G>A (p.Ala166Thr) | Combined oxidative phosphorylation defect type 14 [RCV001853177]|not provided [RCV005241319] | likely benign|uncertain significance | 6 | 5369066 | 5369066 | Human | 1 | name |
| 10411472 | CV211252 | single nucleotide variant | NM_006567.5(FARS2):c.506A>T (p.Asp169Val) | Combined oxidative phosphorylation defect type 14 [RCV000557427]|FARS2-related disorder [RCV003937732]|not provided [RCV000200335] | likely pathogenic|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 6 | 5369076 | 5369076 | Human | 1 | name , trait , alternate_id |
| 10410977 | CV211253 | single nucleotide variant | NM_006567.5(FARS2):c.550G>A (p.Asp184Asn) | Combined oxidative phosphorylation defect type 14 [RCV000535882]|Combined oxidative phosphorylation defect type 14 [RCV003224222]|Inborn genetic diseases [RCV002517211]|See cases [RCV002252050]|not provided [RCV000199293] | likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 6 | 5369120 | 5369120 | Human | 3 | name |
| 10409556 | CV211254 | single nucleotide variant | NM_006567.5(FARS2):c.667C>T (p.Arg223Cys) | Combined oxidative phosphorylation defect type 14 [RCV000650594]|not provided [RCV000196357] | likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 6 | 5404596 | 5404596 | Human | 1 | name |
| 10409192 | CV211255 | single nucleotide variant | NM_006567.5(FARS2):c.899A>G (p.Asn300Ser) | Combined oxidative phosphorylation defect type 14 [RCV001242815]|not provided [RCV000195620] | uncertain significance | 6 | 5431167 | 5431167 | Human | 1 | name |
| 10411347 | CV211256 | single nucleotide variant | NM_006567.5(FARS2):c.904G>T (p.Ala302Ser) | Combined oxidative phosphorylation defect type 14 [RCV001348670] | uncertain significance | 6 | 5431172 | 5431172 | Human | 1 | name |
| 10409619 | CV211257 | single nucleotide variant | NM_006567.5(FARS2):c.971A>G (p.Tyr324Cys) | Combined oxidative phosphorylation defect type 14 [RCV000541945]|not provided [RCV000196488] | likely pathogenic|uncertain significance | 6 | 5545246 | 5545246 | Human | 1 | name |
| 10410474 | CV211258 | single nucleotide variant | NM_006567.5(FARS2):c.989G>A (p.Arg330His) | Combined oxidative phosphorylation defect type 14 [RCV001215842]|not provided [RCV000677021] | likely pathogenic|uncertain significance | 6 | 5545264 | 5545264 | Human | 1 | name |
| 155965625 | CV2155989 | single nucleotide variant | NM_006567.5(FARS2):c.388C>T (p.Leu130Phe) | Combined oxidative phosphorylation defect type 14 [RCV003015682] | uncertain significance | 6 | 5368958 | 5368958 | Human | 1 | name |
| 156341851 | CV2174960 | single nucleotide variant | NM_006567.5(FARS2):c.999G>T (p.Trp333Cys) | Combined oxidative phosphorylation defect type 14 [RCV003047780] | uncertain significance | 6 | 5545274 | 5545274 | Human | 1 | name |
| 156048809 | CV2220224 | single nucleotide variant | NM_006567.5(FARS2):c.697A>G (p.Met233Val) | Inborn genetic diseases [RCV002692718] | uncertain significance | 6 | 5404626 | 5404626 | Human | 1 | name |
| 155981787 | CV2244117 | single nucleotide variant | NM_006567.5(FARS2):c.758A>G (p.His253Arg) | Inborn genetic diseases [RCV002777779] | uncertain significance | 6 | 5404687 | 5404687 | Human | 1 | name |
| 156207024 | CV2307840 | single nucleotide variant | NM_006567.5(FARS2):c.892C>G (p.Leu298Val) | Inborn genetic diseases [RCV002893517] | uncertain significance | 6 | 5431160 | 5431160 | Human | 1 | name |
| 155970343 | CV2309177 | single nucleotide variant | NM_006567.5(FARS2):c.754G>C (p.Ala252Pro) | Inborn genetic diseases [RCV002906871] | uncertain significance | 6 | 5404683 | 5404683 | Human | 1 | name |
| 11531317 | CV247570 | single nucleotide variant | NM_006567.5(FARS2):c.973G>T (p.Asp325Tyr) | Combined oxidative phosphorylation defect type 14 [RCV000239485] | pathogenic|likely pathogenic | 6 | 5545248 | 5545248 | Human | 1 | name |
| 11531338 | CV247571 | single nucleotide variant | NM_006567.5(FARS2):c.424G>T (p.Asp142Tyr) | Hereditary spastic paraplegia 77 [RCV000239526] | pathogenic | 6 | 5368994 | 5368994 | Human | 1 | name |
| 401828462 | CV2743387 | single nucleotide variant | NM_006567.5(FARS2):c.862G>C (p.Val288Leu) | Hereditary spastic paraplegia 77 [RCV003326229] | uncertain significance | 6 | 5431130 | 5431130 | Human | 1 | name |
| 401936268 | CV2803039 | single nucleotide variant | NM_006567.5(FARS2):c.509C>T (p.Ala170Val) | FARS2-related disorder [RCV003414271] | uncertain significance | 6 | 5369079 | 5369079 | Human | | name , trait , alternate_id |
| 401940641 | CV2842121 | single nucleotide variant | NM_006567.5(FARS2):c.593G>T (p.Arg198Leu) | Combined oxidative phosphorylation defect type 14 [RCV003459881] | pathogenic|uncertain significance | 6 | 5369163 | 5369163 | Human | 1 | name |
| 405044673 | CV3031200 | single nucleotide variant | NM_006567.5(FARS2):c.475C>T (p.His159Tyr) | Combined oxidative phosphorylation defect type 14 [RCV003654007] | uncertain significance | 6 | 5369045 | 5369045 | Human | 1 | name |
| 405046176 | CV3035509 | single nucleotide variant | NM_006567.5(FARS2):c.925G>C (p.Gly309Arg) | Combined oxidative phosphorylation defect type 14 [RCV003654079] | likely pathogenic | 6 | 5545200 | 5545200 | Human | 1 | name |
| 405036949 | CV3075870 | single nucleotide variant | NM_006567.5(FARS2):c.829A>G (p.Met277Val) | Combined oxidative phosphorylation defect type 14 [RCV003652792] | benign | 6 | 5431097 | 5431097 | Human | 1 | name |
| 402467331 | CV3174065 | single nucleotide variant | NM_006567.5(FARS2):c.442C>T (p.Arg148Trp) | Combined oxidative phosphorylation defect type 14 [RCV003873348] | uncertain significance | 6 | 5369012 | 5369012 | Human | 1 | name |
| 405763124 | CV3253108 | single nucleotide variant | NM_006567.5(FARS2):c.362C>A (p.Thr121Lys) | Inborn genetic diseases [RCV004383824] | uncertain significance | 6 | 5368932 | 5368932 | Human | 1 | name |
| 405763131 | CV3253109 | single nucleotide variant | NM_006567.5(FARS2):c.395C>T (p.Pro132Leu) | Inborn genetic diseases [RCV004383825] | uncertain significance | 6 | 5368965 | 5368965 | Human | 1 | name |
| 407492629 | CV3432137 | single nucleotide variant | NM_006567.5(FARS2):c.753G>A (p.Met251Ile) | Inborn genetic diseases [RCV004620835] | uncertain significance | 6 | 5404682 | 5404682 | Human | 1 | name |
| 407492633 | CV3432138 | single nucleotide variant | NM_006567.5(FARS2):c.310C>A (p.Arg104Ser) | Inborn genetic diseases [RCV004620836] | uncertain significance | 6 | 5368880 | 5368880 | Human | 1 | name |
| 12743152 | CV361312 | single nucleotide variant | NM_006567.5(FARS2):c.361A>G (p.Thr121Ala) | Combined oxidative phosphorylation defect type 14 [RCV001851007]|Inborn genetic diseases [RCV005338159]|not provided [RCV000416085] | uncertain significance | 6 | 5368931 | 5368931 | Human | 2 | name |
| 12848952 | CV363986 | single nucleotide variant | NM_006567.5(FARS2):c.973G>A (p.Asp325Asn) | Combined oxidative phosphorylation defect type 14 [RCV001067537]|not provided [RCV000421435]|not specified [RCV003330663] | uncertain significance | 6 | 5545248 | 5545248 | Human | 1 | name |
| 12848789 | CV368991 | single nucleotide variant | NM_006567.5(FARS2):c.646C>T (p.Gln216Ter) | Combined oxidative phosphorylation defect type 14 [RCV001389847]|FARS2-related disorder [RCV003418132]|not provided [RCV000418107] | pathogenic|likely pathogenic | 6 | 5404575 | 5404575 | Human | 1 | name , trait , alternate_id |
| 597963659 | CV3754194 | single nucleotide variant | NM_006567.5(FARS2):c.932C>T (p.Ala311Val) | Combined oxidative phosphorylation defect type 14 [RCV005082301] | uncertain significance | 6 | 5545207 | 5545207 | Human | 1 | name |
| 597885746 | CV3800017 | single nucleotide variant | NM_006567.5(FARS2):c.646C>G (p.Gln216Glu) | Combined oxidative phosphorylation defect type 14 [RCV005150496] | uncertain significance | 6 | 5404575 | 5404575 | Human | 1 | name |
| 597910375 | CV3806596 | single nucleotide variant | NM_006567.5(FARS2):c.340G>A (p.Asp114Asn) | Combined oxidative phosphorylation defect type 14 [RCV005154163] | uncertain significance | 6 | 5368910 | 5368910 | Human | 1 | name |
| 597912405 | CV3807107 | single nucleotide variant | NM_006567.5(FARS2):c.593G>A (p.Arg198Gln) | Combined oxidative phosphorylation defect type 14 [RCV005154477] | uncertain significance | 6 | 5369163 | 5369163 | Human | 1 | name |
| 597860387 | CV3832920 | single nucleotide variant | NM_006567.5(FARS2):c.528T>A (p.Asp176Glu) | Combined oxidative phosphorylation defect type 14 [RCV005174833] | uncertain significance | 6 | 5369098 | 5369098 | Human | 1 | name |
| 597956985 | CV3838362 | single nucleotide variant | NM_006567.5(FARS2):c.911C>T (p.Ala304Val) | Combined oxidative phosphorylation defect type 14 [RCV005191737] | uncertain significance | 6 | 5545186 | 5545186 | Human | 1 | name |
| 597907028 | CV3853515 | single nucleotide variant | NM_006567.5(FARS2):c.976A>G (p.Ile326Val) | Combined oxidative phosphorylation defect type 14 [RCV005202994] | uncertain significance | 6 | 5545251 | 5545251 | Human | 1 | name |
| 597925766 | CV3863541 | single nucleotide variant | NM_006567.5(FARS2):c.413G>A (p.Arg138Lys) | not provided [RCV005205866] | uncertain significance | 6 | 5368983 | 5368983 | Human | | name |
| 598128187 | CV3883208 | single nucleotide variant | NM_006567.5(FARS2):c.595C>T (p.Leu199Phe) | not provided [RCV005234741] | uncertain significance | 6 | 5369165 | 5369165 | Human | | name |
| 598125936 | CV3883363 | single nucleotide variant | NM_006567.5(FARS2):c.541G>A (p.Asp181Asn) | Combined oxidative phosphorylation defect type 14 [RCV005233234] | likely pathogenic | 6 | 5369111 | 5369111 | Human | 1 | name |
| 13492848 | CV455655 | single nucleotide variant | NM_006567.5(FARS2):c.344A>G (p.Asn115Ser) | Combined oxidative phosphorylation defect type 14 [RCV000557742]|Inborn genetic diseases [RCV004619340] | likely benign|uncertain significance | 6 | 5368914 | 5368914 | Human | 2 | name |
| 13465568 | CV455850 | single nucleotide variant | NM_006567.5(FARS2):c.407C>A (p.Pro136His) | Combined oxidative phosphorylation defect type 14 [RCV000542910]|Combined oxidative phosphorylation defect type 14 [RCV005398839]|FARS2-related disorder [RCV005056163]|not provided [RCV001545144] | pathogenic|likely pathogenic|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 6 | 5368977 | 5368977 | Human | 2 | name , trait , alternate_id |
| 13470644 | CV455852 | single nucleotide variant | NM_006567.5(FARS2):c.497C>T (p.Ala166Val) | Combined oxidative phosphorylation defect type 14 [RCV000546306]|Combined oxidative phosphorylation defect type 14 [RCV002483484]|not provided [RCV003222035] | conflicting interpretations of pathogenicity|uncertain significance | 6 | 5369067 | 5369067 | Human | 2 | name |
| 13479414 | CV455854 | single nucleotide variant | NM_006567.5(FARS2):c.563A>G (p.Tyr188Cys) | Combined oxidative phosphorylation defect type 14 [RCV000550511] | uncertain significance | 6 | 5369133 | 5369133 | Human | 1 | name |
| 13476745 | CV456258 | single nucleotide variant | NM_006567.5(FARS2):c.676C>T (p.His226Tyr) | Combined oxidative phosphorylation defect type 14 [RCV000549295]|FARS2-related disorder [RCV003935503] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 6 | 5404605 | 5404605 | Human | 1 | name , trait , alternate_id |
| 13475985 | CV456263 | single nucleotide variant | NM_006567.5(FARS2):c.754G>A (p.Ala252Thr) | Combined oxidative phosphorylation defect type 14 [RCV000548968] | uncertain significance | 6 | 5404683 | 5404683 | Human | 1 | name |
| 13477839 | CV456585 | single nucleotide variant | NM_006567.5(FARS2):c.919C>T (p.Arg307Ter) | Combined oxidative phosphorylation defect type 14 [RCV000527357]|FARS2-related disorder [RCV004579555]|not provided [RCV000598985] | pathogenic|likely pathogenic|uncertain significance | 6 | 5545194 | 5545194 | Human | 1 | name , trait , alternate_id |
| 13508659 | CV481208 | single nucleotide variant | NM_006567.5(FARS2):c.461C>T (p.Ala154Val) | Combined oxidative phosphorylation defect type 14 [RCV001246829]|Hereditary spastic paraplegia 77 [RCV000578201] | pathogenic|likely pathogenic|uncertain significance | 6 | 5369031 | 5369031 | Human | 2 | name |
| 8604384 | CV48423 | single nucleotide variant | NM_006567.5(FARS2):c.431A>G (p.Tyr144Cys) | Combined oxidative phosphorylation defect type 14 [RCV000033044]|Mitochondrial encephalomyopathy [RCV000162158]|not provided [RCV000497519] | pathogenic|likely pathogenic | 6 | 5369001 | 5369001 | Human | 4 | name |
| 8604385 | CV48424 | single nucleotide variant | NM_006567.5(FARS2):c.986T>C (p.Ile329Thr) | Combined oxidative phosphorylation defect type 14 [RCV000033045] | pathogenic|likely pathogenic | 6 | 5545261 | 5545261 | Human | 1 | name |
| 13532367 | CV511685 | single nucleotide variant | NM_006567.5(FARS2):c.801C>G (p.Tyr267Ter) | Combined oxidative phosphorylation defect type 14 [RCV001225070]|Inborn genetic diseases [RCV000624131] | pathogenic | 6 | 5431069 | 5431069 | Human | 2 | name |
| 13623058 | CV522053 | single nucleotide variant | NM_006567.5(FARS2):c.730A>C (p.Lys244Gln) | Combined oxidative phosphorylation defect type 14 [RCV000650596]|not provided [RCV005409703] | uncertain significance | 6 | 5404659 | 5404659 | Human | 1 | name |
| 13623061 | CV522411 | single nucleotide variant | NM_006567.5(FARS2):c.411C>A (p.Ser137Arg) | Combined oxidative phosphorylation defect type 14 [RCV000650599]|Inborn genetic diseases [RCV004972822] | uncertain significance | 6 | 5368981 | 5368981 | Human | 2 | name |
| 13623112 | CV522412 | single nucleotide variant | NM_006567.5(FARS2):c.781A>T (p.Ile261Leu) | Combined oxidative phosphorylation defect type 14 [RCV000650593]|Combined oxidative phosphorylation defect type 14 [RCV005392239]|Inborn genetic diseases [RCV002531964] | uncertain significance | 6 | 5431049 | 5431049 | Human | 3 | name |
| 13838656 | CV536153 | single nucleotide variant | NM_006567.5(FARS2):c.422G>A (p.Gly141Glu) | Hereditary spastic paraplegia 77 [RCV000735807] | uncertain significance | 6 | 5368992 | 5368992 | Human | 1 | name |
| 13802699 | CV560763 | single nucleotide variant | NM_006567.5(FARS2):c.578A>G (p.Gln193Arg) | Combined oxidative phosphorylation defect type 14 [RCV000698505] | uncertain significance | 6 | 5369148 | 5369148 | Human | 1 | name |
| 13802862 | CV565755 | single nucleotide variant | NM_006567.5(FARS2):c.839A>C (p.Asn280Thr) | Combined oxidative phosphorylation defect type 14 [RCV000698704] | benign|uncertain significance | 6 | 5431107 | 5431107 | Human | 1 | name |
| 13827689 | CV578608 | single nucleotide variant | NM_006567.5(FARS2):c.310C>T (p.Arg104Cys) | Combined oxidative phosphorylation defect type 14 [RCV000714913] | uncertain significance | 6 | 5368880 | 5368880 | Human | 1 | name |
| 13827690 | CV578609 | single nucleotide variant | NM_006567.5(FARS2):c.332C>T (p.Ser111Leu) | Combined oxidative phosphorylation defect type 14 [RCV000714914]|not provided [RCV004588158] | uncertain significance | 6 | 5368902 | 5368902 | Human | 1 | name |
| 13827692 | CV578611 | single nucleotide variant | NM_006567.5(FARS2):c.426C>A (p.Asp142Glu) | Combined oxidative phosphorylation defect type 14 [RCV000714917] | uncertain significance | 6 | 5368996 | 5368996 | Human | 1 | name |
| 13827710 | CV578612 | single nucleotide variant | NM_006567.5(FARS2):c.457A>G (p.Arg153Gly) | Combined oxidative phosphorylation defect type 14 [RCV000714940] | likely pathogenic|conflicting interpretations of pathogenicity | 6 | 5369027 | 5369027 | Human | 1 | name |
| 13827716 | CV578613 | single nucleotide variant | NM_006567.5(FARS2):c.467C>T (p.Thr156Met) | Combined oxidative phosphorylation defect type 14 [RCV000714948]|not provided [RCV003326510] | pathogenic|likely pathogenic|conflicting interpretations of pathogenicity | 6 | 5369037 | 5369037 | Human | 1 | name |
| 13827693 | CV578614 | single nucleotide variant | NM_006567.5(FARS2):c.476A>C (p.His159Pro) | Combined oxidative phosphorylation defect type 14 [RCV000714919]|Hereditary spastic paraplegia 77 [RCV000714941] | likely pathogenic|uncertain significance | 6 | 5369046 | 5369046 | Human | 2 | name |
| 13827711 | CV578615 | single nucleotide variant | NM_006567.5(FARS2):c.530T>A (p.Val177Asp) | Combined oxidative phosphorylation defect type 14 [RCV000714942] | likely pathogenic | 6 | 5369100 | 5369100 | Human | 1 | name |
| 13827696 | CV578618 | single nucleotide variant | NM_006567.5(FARS2):c.638A>G (p.Glu213Gly) | Combined oxidative phosphorylation defect type 14 [RCV000714922] | uncertain significance | 6 | 5404567 | 5404567 | Human | 1 | name |
| 13827697 | CV578619 | single nucleotide variant | NM_006567.5(FARS2):c.706G>A (p.Val236Met) | Combined oxidative phosphorylation defect type 14 [RCV000714923] | uncertain significance | 6 | 5404635 | 5404635 | Human | 1 | name |
| 13827698 | CV578620 | single nucleotide variant | NM_006567.5(FARS2):c.748C>T (p.Leu250Phe) | Combined oxidative phosphorylation defect type 14 [RCV000714924] | uncertain significance | 6 | 5404677 | 5404677 | Human | 1 | name |
| 13827712 | CV578624 | single nucleotide variant | NM_006567.5(FARS2):c.925G>A (p.Gly309Ser) | Combined oxidative phosphorylation defect type 14 [RCV000714943]|not provided [RCV001092144] | pathogenic|likely pathogenic | 6 | 5545200 | 5545200 | Human | 1 | name |
| 14720990 | CV635005 | single nucleotide variant | NM_006567.5(FARS2):c.509C>G (p.Ala170Gly) | Combined oxidative phosphorylation defect type 14 [RCV000813261] | likely benign|uncertain significance | 6 | 5369079 | 5369079 | Human | 1 | name |
| 14743122 | CV635006 | single nucleotide variant | NM_006567.5(FARS2):c.545A>G (p.Gln182Arg) | Combined oxidative phosphorylation defect type 14 [RCV000823227] | uncertain significance | 6 | 5369115 | 5369115 | Human | 1 | name |
| 14728237 | CV635007 | single nucleotide variant | NM_006567.5(FARS2):c.692A>T (p.His231Leu) | Combined oxidative phosphorylation defect type 14 [RCV000816426] | uncertain significance | 6 | 5404621 | 5404621 | Human | 1 | name |
| 14723788 | CV635008 | single nucleotide variant | NM_006567.5(FARS2):c.781A>G (p.Ile261Val) | Combined oxidative phosphorylation defect type 14 [RCV000798111] | likely benign|uncertain significance | 6 | 5431049 | 5431049 | Human | 1 | name |
| 14740033 | CV635010 | single nucleotide variant | NM_006567.5(FARS2):c.882G>C (p.Met294Ile) | Combined oxidative phosphorylation defect type 14 [RCV000821621] | uncertain significance | 6 | 5431150 | 5431150 | Human | 1 | name |
| 26913597 | CV832068 | single nucleotide variant | NM_006567.5(FARS2):c.629A>G (p.Lys210Arg) | Combined oxidative phosphorylation defect type 14 [RCV001054348]|Inborn genetic diseases [RCV003259065] | uncertain significance | 6 | 5404558 | 5404558 | Human | 2 | name |
| 26899463 | CV832069 | single nucleotide variant | NM_006567.5(FARS2):c.649C>G (p.Leu217Val) | Combined oxidative phosphorylation defect type 14 [RCV001049242] | uncertain significance | 6 | 5404578 | 5404578 | Human | 1 | name |
| 26899759 | CV832070 | single nucleotide variant | NM_006567.5(FARS2):c.694A>G (p.Thr232Ala) | Combined oxidative phosphorylation defect type 14 [RCV001035105] | uncertain significance | 6 | 5404623 | 5404623 | Human | 1 | name |
| 26896878 | CV832071 | single nucleotide variant | NM_006567.5(FARS2):c.846T>A (p.His282Gln) | Combined oxidative phosphorylation defect type 14 [RCV001048277] | benign|uncertain significance | 6 | 5431114 | 5431114 | Human | 1 | name |
| 26895839 | CV832072 | single nucleotide variant | NM_006567.5(FARS2):c.914A>G (p.Gln305Arg) | Combined oxidative phosphorylation defect type 14 [RCV001069752] | uncertain significance | 6 | 5545189 | 5545189 | Human | 1 | name |
| 26884850 | CV832073 | single nucleotide variant | NM_006567.5(FARS2):c.958G>A (p.Ala320Thr) | Combined oxidative phosphorylation defect type 14 [RCV001043192] | uncertain significance | 6 | 5545233 | 5545233 | Human | 1 | name |
| 26922282 | CV832074 | single nucleotide variant | NM_006567.5(FARS2):c.958G>T (p.Ala320Ser) | Combined oxidative phosphorylation defect type 14 [RCV001061787] | uncertain significance | 6 | 5545233 | 5545233 | Human | 1 | name |
| 38457157 | CV919043 | single nucleotide variant | NM_006567.5(FARS2):c.559C>G (p.His187Asp) | Combined oxidative phosphorylation defect type 14 [RCV001196436] | uncertain significance | 6 | 5369129 | 5369129 | Human | 1 | name |
| 38487646 | CV924383 | single nucleotide variant | NM_006567.5(FARS2):c.410G>C (p.Ser137Thr) | Combined oxidative phosphorylation defect type 14 [RCV001220834] | uncertain significance | 6 | 5368980 | 5368980 | Human | 1 | name |
| 38487584 | CV924384 | single nucleotide variant | NM_006567.5(FARS2):c.575A>C (p.His192Pro) | Combined oxidative phosphorylation defect type 14 [RCV001220788] | uncertain significance | 6 | 5369145 | 5369145 | Human | 1 | name |
| 38493192 | CV924385 | single nucleotide variant | NM_006567.5(FARS2):c.673G>A (p.Ala225Thr) | Combined oxidative phosphorylation defect type 14 [RCV001224104] | uncertain significance | 6 | 5404602 | 5404602 | Human | 1 | name |
| 38489670 | CV924386 | single nucleotide variant | NM_006567.5(FARS2):c.674C>T (p.Ala225Val) | Combined oxidative phosphorylation defect type 14 [RCV001221805]|Inborn genetic diseases [RCV002562536]|not provided [RCV001577967] | uncertain significance | 6 | 5404603 | 5404603 | Human | 2 | name |
| 38491047 | CV924387 | single nucleotide variant | NM_006567.5(FARS2):c.874G>A (p.Gly292Arg) | Combined oxidative phosphorylation defect type 14 [RCV001222564] | uncertain significance | 6 | 5431142 | 5431142 | Human | 1 | name |
| 38491432 | CV924388 | single nucleotide variant | NM_006567.5(FARS2):c.905C>T (p.Ala302Val) | Combined oxidative phosphorylation defect type 14 [RCV001222832] | uncertain significance | 6 | 5545180 | 5545180 | Human | 1 | name |
| 38473830 | CV924389 | single nucleotide variant | NM_006567.5(FARS2):c.988C>T (p.Arg330Cys) | Combined oxidative phosphorylation defect type 14 [RCV001214502]|Hereditary spastic paraplegia 77 [RCV002283529]|not provided [RCV002284473] | uncertain significance | 6 | 5545263 | 5545263 | Human | 2 | name |
| 38484201 | CV933368 | single nucleotide variant | NM_006567.5(FARS2):c.455T>G (p.Leu152Arg) | Combined oxidative phosphorylation defect type 14 [RCV001207951] | uncertain significance | 6 | 5369025 | 5369025 | Human | 1 | name |
| 38470496 | CV933370 | single nucleotide variant | NM_006567.5(FARS2):c.961A>G (p.Met321Val) | Combined oxidative phosphorylation defect type 14 [RCV001202603] | uncertain significance | 6 | 5545236 | 5545236 | Human | 1 | name |
| 38477407 | CV945073 | single nucleotide variant | NM_006567.5(FARS2):c.382A>T (p.Ser128Cys) | Combined oxidative phosphorylation defect type 14 [RCV001233474] | uncertain significance | 6 | 5368952 | 5368952 | Human | 1 | name |
| 38461562 | CV945074 | single nucleotide variant | NM_006567.5(FARS2):c.625A>G (p.Ile209Val) | Combined oxidative phosphorylation defect type 14 [RCV001229561]|Inborn genetic diseases [RCV003284087] | likely benign|uncertain significance | 6 | 5404554 | 5404554 | Human | 2 | name |
| 38493385 | CV954504 | single nucleotide variant | NM_006567.5(FARS2):c.886C>T (p.Gln296Ter) | Combined oxidative phosphorylation defect type 14 [RCV001240651] | pathogenic | 6 | 5431154 | 5431154 | Human | 1 | name |
| 126764129 | CV991559 | single nucleotide variant | NM_006567.5(FARS2):c.655G>C (p.Glu219Gln) | Combined oxidative phosphorylation defect type 14 [RCV001300973] | uncertain significance | 6 | 5404584 | 5404584 | Human | 1 | name |
| 126735889 | CV991560 | single nucleotide variant | NM_006567.5(FARS2):c.668G>A (p.Arg223His) | Combined oxidative phosphorylation defect type 14 [RCV001295146] | uncertain significance | 6 | 5404597 | 5404597 | Human | 1 | name |
| 126748467 | CV991561 | single nucleotide variant | NM_006567.5(FARS2):c.751A>G (p.Met251Val) | Combined oxidative phosphorylation defect type 14 [RCV001296936] | uncertain significance | 6 | 5404680 | 5404680 | Human | 1 | name |
| 126761911 | CV991562 | single nucleotide variant | NM_006567.5(FARS2):c.752T>C (p.Met251Thr) | Combined oxidative phosphorylation defect type 14 [RCV001309739] | uncertain significance | 6 | 5404681 | 5404681 | Human | 1 | name |
| 126750569 | CV1006718 | single nucleotide variant | NM_006567.5(FARS2):c.1210C>T (p.His404Tyr) | Combined oxidative phosphorylation defect type 14 [RCV001315944] | uncertain significance | 6 | 5613313 | 5613313 | Human | 1 | name |
| 126730865 | CV1020282 | single nucleotide variant | NM_006567.5(FARS2):c.1004A>T (p.Glu335Val) | Hereditary spastic paraplegia 77 [RCV001333554] | uncertain significance | 6 | 5545279 | 5545279 | Human | 1 | name |
| 126774610 | CV1027260 | single nucleotide variant | NM_006567.5(FARS2):c.1006G>A (p.Asp336Asn) | Combined oxidative phosphorylation defect type 14 [RCV001347420] | uncertain significance | 6 | 5545281 | 5545281 | Human | 1 | name |
| 126749711 | CV1027261 | single nucleotide variant | NM_006567.5(FARS2):c.1199A>G (p.Asp400Gly) | Combined oxidative phosphorylation defect type 14 [RCV001337902] | uncertain significance | 6 | 5613302 | 5613302 | Human | 1 | name |
| 126774366 | CV1027331 | single nucleotide variant | NM_006567.5(FARS2):c.1261A>G (p.Met421Val) | Combined oxidative phosphorylation defect type 14 [RCV001347146] | uncertain significance | 6 | 5771334 | 5771334 | Human | 1 | name |
| 127258205 | CV1060772 | single nucleotide variant | NM_006567.5(FARS2):c.1156C>T (p.Arg386Ter) | Combined oxidative phosphorylation defect type 14 [RCV001386898]|FARS2-related disorder [RCV004550098]|not provided [RCV004728703] | pathogenic|likely pathogenic | 6 | 5613259 | 5613259 | Human | 1 | name , trait , alternate_id |
| 151784786 | CV1344737 | single nucleotide variant | NM_006567.5(FARS2):c.1064A>G (p.Gln355Arg) | Combined oxidative phosphorylation defect type 14 [RCV001989462] | uncertain significance | 6 | 5545339 | 5545339 | Human | 1 | name |
| 151744154 | CV1368032 | single nucleotide variant | NM_006567.5(FARS2):c.1157G>A (p.Arg386Gln) | Combined oxidative phosphorylation defect type 14 [RCV001871325] | uncertain significance | 6 | 5613260 | 5613260 | Human | 1 | name |
| 151846825 | CV1368637 | single nucleotide variant | NM_006567.5(FARS2):c.1013G>A (p.Arg338His) | Combined oxidative phosphorylation defect type 14 [RCV001936818]|not provided [RCV003313253] | likely pathogenic|uncertain significance | 6 | 5545288 | 5545288 | Human | 1 | name |
| 151789639 | CV1377225 | single nucleotide variant | NM_006567.5(FARS2):c.1181A>G (p.Glu394Gly) | Combined oxidative phosphorylation defect type 14 [RCV001898052] | uncertain significance | 6 | 5613284 | 5613284 | Human | 1 | name |
| 151818438 | CV1390562 | single nucleotide variant | NM_006567.5(FARS2):c.1306G>A (p.Ala436Thr) | Combined oxidative phosphorylation defect type 14 [RCV001954514] | uncertain significance | 6 | 5771379 | 5771379 | Human | 1 | name |
| 151823581 | CV1397760 | single nucleotide variant | NM_006567.5(FARS2):c.1213C>T (p.Pro405Ser) | Combined oxidative phosphorylation defect type 14 [RCV001975982] | uncertain significance | 6 | 5613316 | 5613316 | Human | 1 | name |
| 151766508 | CV1410231 | single nucleotide variant | NM_006567.5(FARS2):c.1293G>T (p.Arg431Ser) | Combined oxidative phosphorylation defect type 14 [RCV001987830] | uncertain significance | 6 | 5771366 | 5771366 | Human | 1 | name |
| 151771526 | CV1410907 | single nucleotide variant | NM_006567.5(FARS2):c.1050G>C (p.Gln350His) | Combined oxidative phosphorylation defect type 14 [RCV001971228] | uncertain significance | 6 | 5545325 | 5545325 | Human | 1 | name |
| 151770217 | CV1429072 | single nucleotide variant | NM_006567.5(FARS2):c.1289T>C (p.Val430Ala) | Combined oxidative phosphorylation defect type 14 [RCV001988166] | uncertain significance | 6 | 5771362 | 5771362 | Human | 1 | name |
| 151837731 | CV1445230 | single nucleotide variant | NM_006567.5(FARS2):c.1186G>A (p.Val396Ile) | Combined oxidative phosphorylation defect type 14 [RCV001994374] | uncertain significance | 6 | 5613289 | 5613289 | Human | 1 | name |
| 151814087 | CV1449287 | single nucleotide variant | NM_006567.5(FARS2):c.1163T>C (p.Ile388Thr) | Combined oxidative phosphorylation defect type 14 [RCV002012732] | uncertain significance | 6 | 5613266 | 5613266 | Human | 1 | name |
| 151753301 | CV1501194 | single nucleotide variant | NM_006567.5(FARS2):c.1312C>G (p.Gln438Glu) | Combined oxidative phosphorylation defect type 14 [RCV001969419] | uncertain significance | 6 | 5771385 | 5771385 | Human | 1 | name |
| 151876855 | CV1508193 | single nucleotide variant | NM_006567.5(FARS2):c.1058A>G (p.Lys353Arg) | Combined oxidative phosphorylation defect type 14 [RCV001961148] | uncertain significance | 6 | 5545333 | 5545333 | Human | 1 | name |
| 151753057 | CV1508623 | single nucleotide variant | NM_006567.5(FARS2):c.1256G>T (p.Arg419Leu) | Combined oxidative phosphorylation defect type 14 [RCV001986491] | likely pathogenic | 6 | 5771329 | 5771329 | Human | 1 | name |
| 151828570 | CV1513857 | single nucleotide variant | NM_006567.5(FARS2):c.1282A>G (p.Arg428Gly) | Combined oxidative phosphorylation defect type 14 [RCV001955450] | uncertain significance | 6 | 5771355 | 5771355 | Human | 1 | name |
| 155709738 | CV1775273 | single nucleotide variant | NM_006567.5(FARS2):c.1193T>A (p.Leu398His) | Combined oxidative phosphorylation defect type 14 [RCV002299411] | uncertain significance | 6 | 5613296 | 5613296 | Human | 1 | name |
| 156216307 | CV1903363 | single nucleotide variant | NM_006567.5(FARS2):c.1262T>C (p.Met421Thr) | Combined oxidative phosphorylation defect type 14 [RCV003084811] | uncertain significance | 6 | 5771335 | 5771335 | Human | 1 | name |
| 156391948 | CV1986352 | single nucleotide variant | NM_006567.5(FARS2):c.1084G>A (p.Ala362Thr) | Combined oxidative phosphorylation defect type 14 [RCV002604751] | uncertain significance | 6 | 5613187 | 5613187 | Human | 1 | name |
| 156338081 | CV1988483 | single nucleotide variant | NM_006567.5(FARS2):c.1312C>A (p.Gln438Lys) | Combined oxidative phosphorylation defect type 14 [RCV002631287] | uncertain significance | 6 | 5771385 | 5771385 | Human | 1 | name |
| 156220374 | CV2025013 | single nucleotide variant | NM_006567.5(FARS2):c.1271C>G (p.Thr424Ser) | Combined oxidative phosphorylation defect type 14 [RCV002712120] | uncertain significance | 6 | 5771344 | 5771344 | Human | 1 | name |
| 156011656 | CV2075659 | single nucleotide variant | NM_006567.5(FARS2):c.1122G>T (p.Glu374Asp) | Combined oxidative phosphorylation defect type 14 [RCV002843906] | uncertain significance | 6 | 5613225 | 5613225 | Human | 1 | name |
| 10411700 | CV211259 | single nucleotide variant | NM_006567.5(FARS2):c.1082C>T (p.Pro361Leu) | Combined oxidative phosphorylation defect type 14 [RCV000525331]|Combined oxidative phosphorylation defect type 14 [RCV005396583]|FARS2-related disorder [RCV004751360]|Hereditary spastic paraplegia 77 [RCV000578164]|Inborn genetic diseases [RCV000622524]|See cas es [RCV003156085]|not provided [RCV000200808] | pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 6 | 5613185 | 5613185 | Human | 3 | name , trait , alternate_id |
| 10410448 | CV211260 | single nucleotide variant | NM_006567.5(FARS2):c.1220C>T (p.Thr407Met) | Combined oxidative phosphorylation defect type 14 [RCV000691495]|not provided [RCV000198201] | likely pathogenic|uncertain significance | 6 | 5771293 | 5771293 | Human | 1 | name |
| 10409959 | CV211261 | single nucleotide variant | NM_006567.5(FARS2):c.1255C>T (p.Arg419Cys) | Combined oxidative phosphorylation defect type 14 [RCV001378476]|Hereditary spastic paraplegia 77 [RCV000578139]|not provided [RCV000197201] | pathogenic|likely pathogenic|uncertain significance | 6 | 5771328 | 5771328 | Human | 2 | name |
| 10410577 | CV211262 | single nucleotide variant | NM_006567.5(FARS2):c.1268G>A (p.Arg423Gln) | Combined oxidative phosphorylation defect type 14 [RCV000554776]|Inborn genetic diseases [RCV002515395]|not provided [RCV000198469]|not specified [RCV003317145] | likely pathogenic|uncertain significance | 6 | 5771341 | 5771341 | Human | 2 | name |
| 155937986 | CV2125855 | single nucleotide variant | NM_006567.5(FARS2):c.1244G>A (p.Arg415His) | Combined oxidative phosphorylation defect type 14 [RCV002971085] | likely pathogenic|uncertain significance | 6 | 5771317 | 5771317 | Human | 1 | name |
| 156281539 | CV2186874 | single nucleotide variant | NM_006567.5(FARS2):c.1110G>A (p.Trp370Ter) | Combined oxidative phosphorylation defect type 14 [RCV003044795] | pathogenic | 6 | 5613213 | 5613213 | Human | 1 | name |
| 156272753 | CV2187506 | single nucleotide variant | NM_006567.5(FARS2):c.1093A>C (p.Asn365His) | Combined oxidative phosphorylation defect type 14 [RCV003044510] | uncertain significance | 6 | 5613196 | 5613196 | Human | 1 | name |
| 155997770 | CV2287070 | single nucleotide variant | NM_006567.5(FARS2):c.1235A>G (p.His412Arg) | Inborn genetic diseases [RCV002865076] | uncertain significance | 6 | 5771308 | 5771308 | Human | 1 | name |
| 401875707 | CV2750076 | single nucleotide variant | NM_006567.5(FARS2):c.1345G>C (p.Gly449Arg) | Combined oxidative phosphorylation defect type 14 [RCV003333493] | uncertain significance | 6 | 5771418 | 5771418 | Human | 1 | name |
| 405083816 | CV2900078 | single nucleotide variant | NM_006567.5(FARS2):c.1154T>C (p.Val385Ala) | Combined oxidative phosphorylation defect type 14 [RCV003535406] | uncertain significance | 6 | 5613257 | 5613257 | Human | 1 | name |
| 405094293 | CV2908138 | single nucleotide variant | NM_006567.5(FARS2):c.1126T>C (p.Tyr376His) | Combined oxidative phosphorylation defect type 14 [RCV003536661] | uncertain significance | 6 | 5613229 | 5613229 | Human | 1 | name |
| 405763118 | CV3253107 | single nucleotide variant | NM_006567.5(FARS2):c.1169G>A (p.Gly390Glu) | Inborn genetic diseases [RCV004383823] | uncertain significance | 6 | 5613272 | 5613272 | Human | 1 | name |
| 597652349 | CV3672131 | single nucleotide variant | NM_006567.5(FARS2):c.1174C>G (p.Leu392Val) | Inborn genetic diseases [RCV004974862] | uncertain significance | 6 | 5613277 | 5613277 | Human | 1 | name |
| 597652355 | CV3672132 | single nucleotide variant | NM_006567.5(FARS2):c.1072A>G (p.Ser358Gly) | Inborn genetic diseases [RCV004974863] | uncertain significance | 6 | 5613175 | 5613175 | Human | 1 | name |
| 597874002 | CV3805552 | single nucleotide variant | NM_006567.5(FARS2):c.1087G>A (p.Val363Met) | Combined oxidative phosphorylation defect type 14 [RCV005148830] | uncertain significance | 6 | 5613190 | 5613190 | Human | 1 | name |
| 12913281 | CV421595 | single nucleotide variant | NM_006567.5(FARS2):c.1256G>A (p.Arg419His) | Combined oxidative phosphorylation defect type 14 [RCV001250393]|Hereditary spastic paraplegia 77 [RCV002509414]|See cases [RCV003156098]|not provided [RCV000493622] | pathogenic|likely pathogenic | 6 | 5771329 | 5771329 | Human | 2 | name |
| 13508870 | CV481384 | single nucleotide variant | NM_006567.5(FARS2):c.1163T>G (p.Ile388Ser) | Combined oxidative phosphorylation defect type 14 [RCV000578458] | likely pathogenic | 6 | 5613266 | 5613266 | Human | 1 | name |
| 8604386 | CV48425 | single nucleotide variant | NM_006567.5(FARS2):c.1172A>T (p.Asp391Val) | Combined oxidative phosphorylation defect type 14 [RCV000033046] | pathogenic|likely pathogenic | 6 | 5613275 | 5613275 | Human | 1 | name |
| 13623059 | CV521702 | single nucleotide variant | NM_006567.5(FARS2):c.1009G>A (p.Glu337Lys) | Combined oxidative phosphorylation defect type 14 [RCV000650597]|Hereditary spastic paraplegia 77 [RCV003320363]|not provided [RCV005401554] | uncertain significance | 6 | 5545284 | 5545284 | Human | 2 | name |
| 13623057 | CV522082 | single nucleotide variant | NM_006567.5(FARS2):c.1069C>T (p.Leu357Phe) | Combined oxidative phosphorylation defect type 14 [RCV000650595]|Inborn genetic diseases [RCV003343977]|not provided [RCV001662708] | uncertain significance | 6 | 5613172 | 5613172 | Human | 2 | name |
| 13813740 | CV563679 | single nucleotide variant | NM_006567.5(FARS2):c.1267C>T (p.Arg423Trp) | Combined oxidative phosphorylation defect type 14 [RCV000690369] | uncertain significance | 6 | 5771340 | 5771340 | Human | 1 | name |
| 13827703 | CV578627 | single nucleotide variant | NM_006567.5(FARS2):c.1054G>T (p.Val352Leu) | Combined oxidative phosphorylation defect type 14 [RCV000714931] | uncertain significance | 6 | 5545329 | 5545329 | Human | 1 | name |
| 13827706 | CV578631 | single nucleotide variant | NM_006567.5(FARS2):c.1094A>G (p.Asn365Ser) | Combined oxidative phosphorylation defect type 14 [RCV000714934] | uncertain significance | 6 | 5613197 | 5613197 | Human | 1 | name |
| 13827707 | CV578632 | single nucleotide variant | NM_006567.5(FARS2):c.1145A>G (p.Tyr382Cys) | Combined oxidative phosphorylation defect type 14 [RCV000714935] | uncertain significance | 6 | 5613248 | 5613248 | Human | 1 | name |
| 13827713 | CV578633 | single nucleotide variant | NM_006567.5(FARS2):c.1156C>G (p.Arg386Gly) | Combined oxidative phosphorylation defect type 14 [RCV000714944] | conflicting interpretations of pathogenicity|uncertain significance | 6 | 5613259 | 5613259 | Human | 1 | name |
| 14712434 | CV635011 | single nucleotide variant | NM_006567.5(FARS2):c.1057A>C (p.Lys353Gln) | Combined oxidative phosphorylation defect type 14 [RCV000793798]|FARS2-related disorder [RCV004751704]|Hereditary spastic paraplegia 77 [RCV001329582]|Inborn genetic diseases [RCV003258971]|not provided [RCV004794456] | likely benign|uncertain significance | 6 | 5545332 | 5545332 | Human | 3 | name , trait , alternate_id |
| 14730446 | CV635012 | single nucleotide variant | NM_006567.5(FARS2):c.1212T>A (p.His404Gln) | Combined oxidative phosphorylation defect type 14 [RCV000817404] | uncertain significance | 6 | 5613315 | 5613315 | Human | 1 | name |
| 15151410 | CV699638 | single nucleotide variant | NM_006567.5(FARS2):c.1280A>G (p.Gln427Arg) | Combined oxidative phosphorylation defect type 14 [RCV000945681]|not provided [RCV001585876] | likely benign|uncertain significance | 6 | 5771353 | 5771353 | Human | 1 | name |
| 26884474 | CV832075 | single nucleotide variant | NM_006567.5(FARS2):c.1001G>A (p.Cys334Tyr) | Combined oxidative phosphorylation defect type 14 [RCV001042969]|not provided [RCV001578008] | likely benign|uncertain significance | 6 | 5545276 | 5545276 | Human | 1 | name |
| 26910211 | CV832076 | single nucleotide variant | NM_006567.5(FARS2):c.1012C>T (p.Arg338Cys) | Combined oxidative phosphorylation defect type 14 [RCV001038614]|Inborn genetic diseases [RCV004619483] | uncertain significance | 6 | 5545287 | 5545287 | Human | 2 | name |
| 26916684 | CV832077 | single nucleotide variant | NM_006567.5(FARS2):c.1129G>A (p.Ala377Thr) | Combined oxidative phosphorylation defect type 14 [RCV001056496]|Inborn genetic diseases [RCV004977947] | likely benign|uncertain significance | 6 | 5613232 | 5613232 | Human | 2 | name |
| 26903829 | CV832078 | single nucleotide variant | NM_006567.5(FARS2):c.1208T>C (p.Val403Ala) | Combined oxidative phosphorylation defect type 14 [RCV001036286] | uncertain significance | 6 | 5613311 | 5613311 | Human | 1 | name |
| 26895774 | CV832155 | single nucleotide variant | NM_006567.5(FARS2):c.1250C>T (p.Thr417Met) | Combined oxidative phosphorylation defect type 14 [RCV001069736] | uncertain significance | 6 | 5771323 | 5771323 | Human | 1 | name |
| 38488137 | CV933371 | single nucleotide variant | NM_006567.5(FARS2):c.1012C>A (p.Arg338Ser) | Combined oxidative phosphorylation defect type 14 [RCV001209613] | uncertain significance | 6 | 5545287 | 5545287 | Human | 1 | name |
| 38495396 | CV945075 | single nucleotide variant | NM_006567.5(FARS2):c.1051A>C (p.Lys351Gln) | Combined oxidative phosphorylation defect type 14 [RCV001225688]|not provided [RCV003313195] | likely benign|uncertain significance | 6 | 5545326 | 5545326 | Human | 1 | name |
| 38482417 | CV945076 | single nucleotide variant | NM_006567.5(FARS2):c.1084G>T (p.Ala362Ser) | Combined oxidative phosphorylation defect type 14 [RCV001235520] | uncertain significance | 6 | 5613187 | 5613187 | Human | 1 | name |
| 38475844 | CV945077 | single nucleotide variant | NM_006567.5(FARS2):c.1217A>G (p.Lys406Arg) | Combined oxidative phosphorylation defect type 14 [RCV001232805] | uncertain significance | 6 | 5613320 | 5613320 | Human | 1 | name |
| 38496284 | CV954796 | single nucleotide variant | NM_006567.5(FARS2):c.1243C>T (p.Arg415Cys) | Combined oxidative phosphorylation defect type 14 [RCV001242460]|Inborn genetic diseases [RCV002564031] | uncertain significance | 6 | 5771316 | 5771316 | Human | 2 | name |
| 38465833 | CV962037 | single nucleotide variant | NM_006567.5(FARS2):c.1113G>T (p.Leu371Phe) | Combined oxidative phosphorylation defect type 14 [RCV001250395] | pathogenic | 6 | 5613216 | 5613216 | Human | 1 | name |
| 155644051 | CV1708373 | microsatellite | NM_006567.5(FARS2):c.821_824del (p.Ser274fs) | Combined oxidative phosphorylation defect type 14 [RCV002290362] | likely pathogenic | 6 | 5431084 | 5431087 | Human | | name |
| 13508652 | CV481210 | microsatellite | NM_006567.5(FARS2):c.515TGG[2] (p.Val174del) | Combined oxidative phosphorylation defect type 14 [RCV001341117]|Hereditary spastic paraplegia 77 [RCV000578192] | pathogenic|uncertain significance | 6 | 5369085 | 5369087 | Human | | name |
| 13521531 | CV495529 | deletion | NM_006567.5(FARS2):c.946_950del (p.Leu316fs) | Combined oxidative phosphorylation defect type 14 [RCV001385178]|not provided [RCV000599526] | pathogenic|likely pathogenic | 6 | 5545219 | 5545223 | Human | 1 | name |
| 155794400 | CV1858522 | deletion | NM_006567.5(FARS2):c.1218-32980_1218-32942del | Schizophrenia [RCV002463484] | uncertain significance | 6 | 5738311 | 5738349 | Human | 2 | name |
| 38465830 | CV962038 | duplication | NM_006567.5(FARS2):c.1269_1276dup (p.Ser426Ter) | Combined oxidative phosphorylation defect type 14 [RCV001250394] | pathogenic|likely pathogenic | 6 | 5771341 | 5771342 | Human | 1 | name |
| 151737432 | CV1380188 | deletion | NM_006567.5(FARS2):c.877del (p.Gly292_Val293insTer) | Combined oxidative phosphorylation defect type 14 [RCV001946748] | pathogenic | 6 | 5431142 | 5431142 | Human | 1 | name |
| 598125934 | CV3883362 | deletion | NM_006567.5(FARS2):c.358_363del (p.Val120_Thr121del) | Combined oxidative phosphorylation defect type 14 [RCV005233233] | likely pathogenic | 6 | 5368927 | 5368932 | Human | 1 | name |
| 156156822 | CV1928136 | deletion | NM_006567.5(FARS2):c.1168_1173del (p.Gly390_Asp391del) | Combined oxidative phosphorylation defect type 14 [RCV002664095]|not specified [RCV004783026] | uncertain significance | 6 | 5613271 | 5613276 | Human | 1 | name |
| 13623060 | CV522083 | indel | NM_006567.5(FARS2):c.1109_1111delinsAACCAGAATGAA (p.Trp370_Leu371delinsTer) | Combined oxidative phosphorylation defect type 14 [RCV000650598] | pathogenic|uncertain significance | 6 | 5613212 | 5613214 | Human | | name |
| 405000184 | CV2852657 | deletion | NC_000006.11:g.(?_5261745)_(5545574_5613401)del | FARS2-related disorder [RCV004554237] | pathogenic | | | | Human | | trait , alternate_id |